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Abstract  
 
  
The redox hemostasis regulation is essential for cellular processing and its 
survival. Uncontrolled regulation of cellular stress related processes and 
signaling leads to the development of different diseases including cancer and 
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cardiac disorders. To date, numerous clinical and experimental studies proved 
that oxidative stress play a key role in cellular signaling regulation that 
contributes in the heart failure and in the several hematopathologies. There is 
need to find specific therapeutic targets that may normalize the body redox 
conditions. Although in previously documented studies stress role in cardiac 
disorder and cancer has been described, but still research is going to address. 
The excessive free radical generation during disease condition that leads to 
oxidative stress is believed to play a key role in cardiac dysfunction and 
hematotoxicity. The persistent oxidative stress due to decreased antioxidants 
enzymes capacity leads to the damage of macromolecules contributing in several 
diseases including cardiac complication and hematotoxicity.   
In the present study the mechanism of redox homeostasis regulation was 
evaluated in cardiac hypertrophy as well as in hematological complications. Our 
findings showed that different stress inducers such as hyperglycemia, serotonin, 
endothelin-1, isoproterenol (ISO) and phenylephrine (PE) generates free radicals 
that leads to oxidative stress. Redox signaling network also get disturbed during 
transverse aortic construction (TAC) and calcineurin transgenic (CnA-Tg) 
cardiac hypertrophic condition, which further participates in the diseases 
progression. In order to reduce and attenuate the pro oxidative stress ROS, potent 
antioxidants such as N-acetyl NAC (N-acetyl, L-cysteine)  and melatonin effects 
were investigated in the present study. Our findings also suggests that potent 
antioxidants have beneficial role in redox homeostasis regulation.   
MicroRNAs are emerging and key regulator in cardiac disorders. Herein, we 
proposed that oxidative stress directly or indirectly alters the miRNA expression 
that contributes in diseases progression. To address this, miRNAs which have 
direct or indirect link to anti-hypertrophic pathway element includ ing 
superoxide dismutase (SOD) were predicted and selected. The altered 
expressions of miRNAs were confirmed in well-established TAC and CnA-Tg 
cardiac hypertrophic mice model. High expression of miR-132, miR-212, miR-
155, miR-17, miR-199b, miR-152, miR146b in TAC and miR-212, miR-199b, 
miR-152 and miR-17 were observed in transgenic mice heart tissue. While miR-
142-3p and miR-92b were down regulated in both cardiac hypertrophy models. 
To determine miRNAs link to oxidative stress, their  
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expressions were observed in HL-1 cells treated with hydrogen peroxide. Dose 
dependent high expression of miR-132, miR-212, miR-152, miR-199b, miR-155 
and miR-146b were observed. While the miR-142-3p as well as miR-17 were 
down regulated upon hydrogen peroxide treatment. Further, miRNAs expression 
were observed in the presence and absence of potent antioxidants (NAC and 
melatonin) in ISO and ET-1 induced cardiac hypertrophy model. miR-152 
expression in the presence of potent antioxidant remained unchanged both in 
ET-1 and ISO induced cardiac hypertrophy model while miR-132 and miR-212 
was down regulated in presence of potent antioxidants. The earlier down 
regulated miR-142-3p in ISO and ET-1 induced hypertrophic model was up 
regulated in the presence of NAC as well as in melatonin group suggest ing 
oxidative stress link to miRNAs regulation.   
Previous studies reported the role of trace elements in diverse physiological and 
pathological systems, but their effects as leading cause of leukemia in Pakistani 
population have not still been addressed. The present investigation also aimed 
to determine the level of oxidative stress regulating trace elements (Fe, Zn, Cu 
and Ni) as well as ROS and SOD status in acute leukemia patients from the 
Pakistani population. The concentrations of free radicals in both AML as well 
as ALL were significantly higher compared to the normal healthy individua ls. 
Serum SOD levels were significantly down regulated in acute leukemia patients. 
Trace element Fe and Zn concentrations were significantly decreased while the 
concentrations of Cu and Ni were increased in leukemia patients compared to 
the normal healthy subjects.  
The ROS level and blast cells count were higher in disease control groups than 
in groups treated with varying amounts of B. persicum extract and the normal 
group. Moreover, there was an imbalance in hematological parameters in 
untreated and treated groups with a correlation between free radicals and plant 
extract administration.  
In summary, many pathological condition accompanied with excessive ROS 
production and deficiency in antioxidant defense that leads to oxidative stress 
which further participate in disease progression including cardiac and 
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hematological disorders. Regulation of oxidative stress offering a possible 
therapeutic approach for cardiac and hematological disorders.   
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Introduction   
Stress induced by several sources play a critical role in regulation of various signa ling 
processes. Uncontrolled regulation of cellular stress related processes and signaling leads 
to the development of different diseases including cancer and cardiac disorders. To date, 
numerous clinical and experimental studies proved that oxidative stress play a key role in 
cellular signaling regulation that contributes in heart failure and in several 
hematopathalogies (Tutsui et al., 2013; Maraldi et al., 2013).   
It is believed that during initial developmental stages cardiac myocytes rapidly prolifera te 
but soon after birth lose their proliferative capacity. Accumulative reports showed that, 
non-muscle cell proliferation regulatory signaling is also involved in cardio myocytes 
hypertrophy due to cell cycle disturbance (Hunter et al., 1999; Sadoshima et al., 1997). 
Moreover, in cardiac hypertrophy which leads to heart failure, a broad variety of 
transcription factors and signaling pathways are activated by Reactive Oxygen Species 
(ROS). ROS contributes in cellular dysfunction, DNA damage, protein and lipid 
peroxidation. The importance of oxidative stress is vigorously emerging with respect to the 
cardiac complication that leads to heart failure (HF). Similarly, evidence for chronic 
oxidative stress has also been found in many cancer types and in hematological disorders 
such as hematoxicity and leukemia (Battisti et al., 2008; Kumar et al., 2008; Sallmyr et al., 
2008)  
MicroRNAs (miRNA) are thought to ‘fine tune’ gene expression under normal homeostatic 
circumstances, but under stress condition the regulatory function of miRNA gets more 
highlighted and seems to play a decisive role in disease process (Xu et al., 2009; van et al., 
2008). Li et al. (2012) reported that microRNA play positive role against ROS (H2O2), thus 
protecting cardio myocytes form oxidative stress and suggesting  link between ROS and  
miRNAs in diseased condition (Endo et al., 2013; Freund-Michel et al., 2013; Tutsui et al., 
2013; Nabeebaccus et al., 2011; Oliveira-Carvalho et al., 2012). Under umbrella of 
documented evidence it is apparent that noncoding small RNAs specifically microRNAs 
play pivotal role in different pathologies including heart failure and leukemia (Zhi et al., 
2013; Zhan et al., 2013; Berniakovich et al., 2012; Oliveira-Carvalho et al., 2012).   
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Part 1  
1.1. Stress as a regulatory factor in cardiac pathologies  
  
  
  
  
  
  
  
  
  
  
  
Heart responds to multiple forms of stress by undergoing cardiac remodeling with 
apparently irreversible changes that further results in dilation, inadequate performance and 
ultimately heart failure. Heart failure (HF) is a condition in which cardiac ventricles are 
unable to collect and distribute blood adequately (Dickstein et al., 2008; Hunt et al., 2009). 
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So far many therapeutic means and tools are available to prolong the life of HF suffering 
patients but its development is poorly understood. According to the study conducted in 
2010, approximately 23 million people are affected worldwide by HF. HF is commonly 
believed to be a disease of the elderly and its prevalence increases with the aging of world 
population. (Lloyd-Jones et al., 2010).   
Types of stresses responsible for various cardiovascular pathologies mentioned below:  
• Oxidative stress: Excessive reactive oxygen species (ROS) generation 
and/or antioxidants deficiencies occurred during many pathological conditions, 
leading to oxidative stress. Basically, oxidative stress is generated through an 
imbalance between free radicals and endogenously produced antioxidants. 
Oxidative stress play a key regulatory role in numerous cellular events. To minimize 
the deleterious effects of oxidative stress, the redox reaction is regulated by body 
defense system composed of several antioxidants enzymes which are responsible 
for the free radical scavenging (Yancey et al., 2015: Zhang et al., 2014).   
• Mechanical stress: Pressure overload induced stress is generated by 
transverse aortic constriction (TAC). TAC mice have been widely used for pressure 
overload induced cardiac hypertrophy. During initial stages TAC leads to the 
compensatory cardiac remodeling but persistent pressure overload due to TAC 
causes maladaptive cardiac hypertrophy that leads ultimately to heart failure  
(deAlmeida et al., 2010; Rockman et al., 1999).    
1.1.1 Factors leading to heart failure  
Heart failure (HF) is considered to be a common consequences of various cardiac 
conditions, including hypertension, rheumatic fever, Ischemic heart disease (IHD), 
cardiopulmonary disease, cardiomyopathy, congenital heart disease and valvular diseases. 
These cardio-pathologies either alone or in concert with other risk factors may lead to heart 
HF.  
1.1.2. Cardiac hypertrophy transition to heart failure   
Cardiac hypertrophy is defined as thickening of intra-ventricular walls. At molecular levels, 
it is characterized by the increase in cardio myocytes size but not the number of cardio 
myocytes (Oka et al., 2008). During stress condition cardiac activities are initially retained 
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by compensatory mechanisms such as hypertrophy, heart intracellular signaling pathway 
activation and stimulation by hemo-dynamic factors. However, prolong and severe hemo-
dynamic overload leads to the depression of cardiac muscle contractility. The mechanism 
of transition from acute adaptive cardiac hypertrophy to heart failure is in fact a series of 
events, including myocytes growth, adults gene down regulation and fetal gene re-
expression, apoptosis as well as necrosis induced myocytes death and changes in the 
extracellular matrix (Topcuoglu et al., 2015; Foo et al., 2005; Hilfiker-Kleiner et al., 2005; 
“Danial et al., 2004; Nadal-Ginard et al., 2003; Wencker et al., 2003; Aoyagi et al., 1993”). 
As the result of these events, increase in the myocardial mass and the chamber dilation 
occurs. Moreover, the impaired systolic and diastolic function further contributes to cardiac 
pump dysfunctions. Numerous stimuli including neuro-hormones, mechanical stress on 
myocytes, inflammatory cytokines and reactive oxygen species, are believed to link 
pathological factors with the myocardium structural and functional signaling (Oka et al., 
2008).   
Cardiac hypertrophy is mainly classified into physiological and pathological hypertrophy 
on the basis of stimulus dependent changes in the cardiac muscles. These types are further 
sub-classified into eccentric hypertrophy, in which heart wall thickness and ventricular 
dilation are increased upon stress induction (volume overload) with the addition of 
sarcomeres in series (Fig. 1.1) and Concentric hypertrophy; which is regarded as the 
myocardium response against stress produced due to pressure overload, and results in 
thickness of the wall with the deposition of new sarcomeres, but the chamber radius may 
not change (Mihl et al., 2008; Pluim et al., 2000; Grossman et al., 1975).   
Hypertrophy and dilation are types of commonly observed cardiac enlargement. Cardiac 
hypertrophy is associated with the thickness of myocardium while dilation involves an 
increase size of the cavity of one or more heart chambers. The most common cause of 
hypertrophy is hypertension (blood pressure) which causes ventricle thickness and aortic 
wall stenosis (Gupta et al., 2007).  Other documented possible causes include abnormal 
heartbeat, weakness of heart muscles, anemia, thyroid disorders, high level of iron in the 
body, protein build up and amyloidosis. These abnormilities cause reduction of adenosine 
triphosphate (ATP) synthesis in mitochondria and ultimately leads to hypertrophy 
progression (Diwan and Dorn, 2007).    
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Figure 1.1: Pattern of cardiac hypertrophy (Bernardo et al., 2010)  
1.1.3. Signal transduction in cardiac hypertrophy   
Numerous signaling pathways including MAPK, IGF3, PKC, PI3K-AKTB, mTOR,  
TNFα, TGFβ and Calcineurin-NFAT system are documented to be involved in the 
development of cardiac hypertrophy (Rohini et al., 2010; Barry et al., 2008). PKC family 
plays an important role in the hypertrophic response and consists of serinethreonine kinases 
activated by calcium and other signaling pathways (Nishizuka,  
1986). TNF-α or Fas ligand involved in extrinsic pro-apoptotic signaling activated during 
pathological condition (Torre-Amione et al., 1996). Similarly, IGF-1 involved in highly 
conserved pathway plays a significant role in muscles growth regulation (Tarone et al., 
2003). The Akt (protein kinase B), central component of this pathway regulate both protein 
synthesis, through ripamycin (mTOR) and glycogen synthase kinase 3β (GSK3β), and 
protein degradation through FoxO family (Schiaffino et al., 2011)  
There are accumulating evidences that myocytes growth is mainly activated by stress 
stimuli, which mediates protein kinase cascades activation (Sadoshima and Izumo., 1997). 
Theses cascades further induce MAPK activation and it is believed that MAPK plays a 
pivotal role in the induction of cardiomyocytes hypertrophy. The MAPK signaling is 
composed of ERK, JNK and p38 which are mainly activated by various types of stress. It 
has been documented that MAPK and calcineurin-NFAT signaling are co-dependent that 
may induce calcineurin activation in cardiomyocytes which in turn leads to the down 
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regulation of the p38 and the up regulation of ERK and JNK. Thus MAPK plays an 
important role in the cardiac hypertrophy regulation (Garrington and Johnson, 1999).  
1.1.4. Calcineurin/ NFAT signaling in cardiac hypertrophy  
The combinatorial interaction between the transcription factors and respective promoter 
elements is required during normal cardiac development and also in pathological conditions 
such as hypertrophy. Calcineurin is a heterodimer phosphatase consisting of two subunits, 
calcineurin A (58-59 kDa) which contains enzyme catalytic site and the other calcineur in 
B, small subunit (19 kDa) having Ca++ binding domain. It dephosphorylates NFAT via 
calmodulin dependent mechanism. NFAT family composed of five members; NFATc1, 
NFATc2, NFATc3, NFATc4 and NFAT5 (Frey et al., 2003; Morimoto et al., 2000; Hornig 
et al., 1998).   
Calcineurin pathway is one of the early discovered signaling pathways that reveals the 
molecular mechanism involved in the signal transduction from cell membrane to nucleus. 
Stress in the form of mechanical and neurohormonal stimuli initiates the calcineur in 
pathway by stimulating calmodulin-Ca++ binding which further regulates the 
dephosphorylation of NFAT via calcineurin (Fig. 1.2). Upon activation NFAT is 
translocated to the nucleus and act as a transcription factor that regulates the hypertrophic 
gene expression including stress markers (Molkentin et al., 1998).    
1.1.5. Factors involved in cardiac hypertrophy  
High blood pressure, obesity, hyperglycemia, aortic stenosis and certain genes are 
associated with cardiac hypertrophy (left ventricle hypertrophy). Pressure/volume over 
load, (Ozaki et al., 2002) metabolic needs (Russell et al., 2000) and release of autocrine 
and paracrine factors such as endothelin-1 (Sussman et al., 2002) are included in the 
hemodynamic factors which may induce left ventricualar hypertrophy. Similar ly, 
dysregulation of neurohumoral factors including catecholamines, sympathetic nervous 
system, angiotensin II and insulin induced oxidative stress also participates in the induction 
of cardiac hypertrophy (Campos et al., 2006; Dash et al., 2003; Brownsey et al., 1997). It 
has also been documented that several physiopathological and genetic conditions includ ing 
increase in angiotensin II concentration, hyper-cholesterolemia, mechanical stress and 
inflammatory process  can induce cardiac oxidative stress (Yao et al., 2006; Sato et al., 
2004; Aikawa et al., 2001; Lang et al., 2000)”.   
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Figure 1.2: Calcineurin/NFAT signaling mechanism (Rohini et al., 2010)    
  
1.1.6. Oxidative stress as regulatory factor in cardiac hypertrophy  
i. Reactive oxygen species generation and oxidative stress   
ROS is a collective term used for short lived diffusible entities including oxygen radicals 
such as “superoxide anion (O2•−), hydroxyl (HO•), peroxy (ROO•), alkoxy (RO•), 
hydroperoxy (HOO•) radicals, non-radicals derivatives such as hydrogen peroxide (H2O2), 
ozone (O3) and singlet oxygen (1O2)” (Choe and Min, 2006). During aerobic respiration, 
molecular oxygen is mainly involved in the production of chemical energy. On one side 
oxygen is essential to live while on the other side it may also be toxic and mutagenic 
(Buonocore et al., 2010). To counterbalance these harmful substances, certain preventive 
and repair mechanisms including physical and antioxidant defenses have to be adopted by 
all living organisms (Buonocore et al., 2010). The ROS overproduction and insufficiency 
of antioxidant mechanisms cause the oxidative stress, which an imbalance between 
excessive ROS production and limitee production of endogenous antioxidants limited 
(Droge, 2002).  
ii. Sources and production of ROS  
All the toxic products of oxygen are included in ROS but not all the ROS can be considered 
as oxygen radicals (Fig. 1.3). ROS have both endogenous and exogenous sources for their 
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production (Auten and Davis, 2009). Mitochondria, peroxisomes, microsomes, cytochrome 
P450 metabolism, inflammatory cell activation, nitric oxide synthase monoxygenase 
system and several other enzymes involved in the inflammatory processes are included in 
the endogenous sources of ROS (Inoue et al., 2003). Environmental factors and xenobiotics 
(metal ion, radiation and barbiturates) are the part of exogenous sources of ROS 
(Chryssostomos et al., 2013; Klaunig et al., 1997).   
  
  
Figure1.3: ROS sources and signaling mechanism (Juan et al., 2006).   
iii. Oxidative stress role in cardiac hypertrophy  
It is reported that redox-sensitive signaling pathways have causative and prominent role in 
the cardiac hypertrophy. Numerous sources such as angiotensin II (Murtaza et al., 2008), 
endothelin-1 (Hirotani et al., 2002) and tumor necrosis factor alpha (TNF- 
a) (Nakamura et al., 1998) induced oxidative stress, have been reported as critical 
contributor of cardiac hypertrophy. ROS induced oxidative stress activates various 
hypertrophy signaling pathways and transcription factors which further participate in the 
pathology. The prominent ROS mediated signaling includes mitogen activated protein 
kinases (MAPK) and nuclear factor k-B (NFkB). The MAPK participates in the cardiac 
hypertrophy via various downstream pathway elements such as ERK, JNK and p38 
regulation (Zhao et al., 2015).  The NFkB has been reported to be a strong mediator of 
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cardiac hypertrophy, upon activation by different stress inducers including endothlin-1 
(ET-1) and phenylephrine (PE) (Gordon et al., 2011).   
The activity of NADPH oxidase that is a major source of the ROS gets increased along with 
the MAPK (Fig. 1.3). Further in vivo and in vitro experimental knock out studies showed 
the involvment of NADPH family members (Heymes et al., 2003; Li et al., 2002). Bendall 
et al., (2002) proposed that NOX2 (NADPH oxidase family member) have pivotal role in 
angiotensin II induced cardiac hypertrophy via NFkB activation. Similarly, Kuroda et al., 
2010) reported NOX4 as a major source in failing heart.   
  
Figure 1.4: serotonin induced proliferation regulatory mechanism (de Caestecker M  
Circulation Research. 2006; 98:1229-1231)   
Our group has recently reported that through its direct or indirect production of free 
radicals, diabetes mellitus act as a major risk factor for many cardiac complicat ions 
including cardiac hypertrophy (Sobia et al, 2015; Ali el al., 2015). It is also well known 
that high glucose induced ROS production which in turn participates in the diabetic 
complications (Giacco et al., 2010) via diverse signaling mechanisms. Enterochromaffin 
(EC) cells of the gut also release serotonin (5-hydroxytryptamine (5-HT) upon lumina l 
glucose stimulation (Masuda et al., 1997; Raybould et al., 2003). Serotonin (5-HT) is a 
biogenic amine produced by numerous cell types, including enterochromaffin cells of the 
gut, a large amount is stored by platelets and released upon activation (Fig. 1.4). Serotonin 
is involved in the stimulation of cardiac sympathetic afferent nerve and causes coronary 
artery contraction during ischemia. This supports the role of serotonin in the regulation of 
myocardial structure and function via its receptors such as 5-HT2B, 5-HT2A, presented on 
the surface of many cell types (Bianchi et al., 2005). Foussal et al (2010) demonstrated that 
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serotonin induces hypertrophy in cardiomyocytes through an intracellular signaling 
pathway involving monoamine oxidase (MAO). These studies support the role of serotonin 
as a stimulus of ROS- mediated cardiac hypertrophy (Bianchi et al., 2005).  
1.1.7. Antioxidants: SOD and Catalase role in heart diseases  
The oxidative stress is dependent on the free radical generation and their elimination by the 
body antioxidant systems. A living cell has a well-defined defense mechanism composed 
of large number of antioxidant enzymes against ROS and redox-signaling, to protect the 
cell from oxidative damage or repair damage caused by free radicals. The three primary 
antioxidants enzymes including superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx) are present in all mammalian cells. SOD (isoforms: SOD1, 
SOD2 and EcSOD) convert superoxide to peroxides (hydrogen peroxide) and molecular 
oxygen. The catalase converts hydrogen peroxide to water and oxygen while GPx reduce 
lipid hydroperoxides and hydrogen peroxide to alcohol and water respectively. The above 
mentioned three antioxidants are considered as the first line of defense against free radicals 
(Fig. 1.5).   
Melatonin (N-acetyl-5-methoxytryptamine) is a lipophilic molecule that play a potent role 
at molecular and physiological level. This hormone is synthesized by pineal gland 
(Hardeland, 2014). Melatonin play its antioxidant role by directly detoxifying free radicals, 
up regulating the expression and production of other antioxidant enzymes (Tomas-Zapico 
et al., 2005), increasing the rate of mitochondrial oxidative phosphorylation and thus 
decreasing free radical production by preventing electron leakage (Leon et al., 2005).   
Similarly, NAC has been used as an antioxidant in various experimental studies and is 
considered a strong antioxidants because of its special structure. It is a combination of L-
cysteine amino acid and an acetyl (-CO-CH3) group attached to (-NH2) group of Lcysteine. 
Since L-cysteine is a precursor of reduced glutathione (GSH), synthesis of GSH contributes 
to the enhancement in the level of this major intracellular antioxidant (Radomska -
Lesniewska and Skopinski, 2012; Sadowska et al., 2006). NAC can therefore normalize 
the disturbed redox status of the cells and influence cell signaling, transcription pathways 
etc. Due to the presence of sulfhydryl group, NAC directly scavenges ROS such as 
superoxide (O2), hydrogen peroxide (H2O2) and hydroxyl radicals (Zafarullah et al., 2003; 
Sadowska et al., 2006).   
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Figure 1.5: Scavenging mechanism of antioxidants (Pandey et al., 2010).   
It has been previously reported by our group that an inadequate antioxidant defense capacity 
plays an important role in cardiac hypertrophy. Murtaza et al., 2008 suggested that in 
cardiomyocytes, catalase is a target of numerous hypertrophic stimuli causing a decrease 
in catalase level and increase in ROS concentration. Similarly, Balta et al., (1999) reported 
decrease in SOD activity in left ventricular hypertrophy induced by isoproterenol treatment. 
The decrease in antioxidant over the increase of oxidative stress shows the key role of 
antioxidant in body defense mechanism in diseases condition.   
1.1.8. miRNA as regulatory factor in heart diseases  
 i.  Biology and biogenesis of MicroRNA   
MicroRNAs (miRNAs) are small noncoding RNAs that play a key role in gene expression 
regulation. Mature microRNAs (18 – to 24- nucleotide-long) are the result of sequentia l 
processing. Initially primary microRNAs are transcribed by RNA ploymerase II (pol II) 
(Lee et al., 2002). Following transcription, the primicroRNAs are cleaved by RNase III 
endonuclease Drosha, resulting in multiple 60-100 base pair long hairpin- like structures 
known as precursor microRNAs (pre-microRNAs) (Bartel et al., 2004). This pre-
microRNAs is then transported to cytoplasm by exportin-5 protein and subsequently 
cleaved again at the base of the hairpin by Dicer enzyme. This results in the double-stranded 
RNA from which only one of the two strands is the mature microRNA. For the gene 
regulation, this mature microRNA become a part of RNA-induced silencing complex 
(RISC) which on binding leads to post-translational gene regulation “(Lee et al., 2003; 
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Schwarz et al., 2003; Yi et al., 2003”). All the processing steps are shown in fig. 1.6. ii. 
Role of microRNA in the stress induced heart complications   
MicroRNAs (miRNA) are thought to ‘fine tune’ gene expression under normal homeostatic 
circumstances, but under stress condition the regulatory function of miRNA gets more 
highlighted and seems to play a decisive role in disease process. Although, miRNA targets 
identification is still a challenging task, since the miRNA targets selection is based upon 
partial Watson-Crick base pairing in short stretches of nucleotides (Xu et al., 2009; van et 
al., 2008). Under certain condition such as stress, some miRNAs are upregulated inducing 
down regulation of its targets and vice versa (Mann et al., 2007).    
Conclusively, the literature review suggests that miRNA dysregulation is involved in the 
pathogenesis and progression of various diseases including cardiac hypertrophy and heart 
failure. To date, numerous miRNAs are discovered which are dramatically regulated under 
acute stress condition (Da Costa et al., 2010; Bell et al., 2010). Accumulated studies 
reported microRNA involvement in the regulation of cardiac hypertrophy leading to heart 
failure. Similarly, miRNA regulation in response to oxidative stress have also been reported 
recently (Shunjian et al., 2012; Li et al., 2012), suggesting link of oxidative stress and 
miRNAs. miRNAs are the potential molecular diagnostic and therapeutic strategies of heart 
failure.   
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Figure 1.6: MicroRNA biogensis mechansim (Winter et al., 2009).  
  
1.1.9. Aims and objectives   
Aims of the present study is to highlight the regulatory factors affecting heart performance 
under stress (oxidative stress) condition. Mainly the following main objectives were 
addressed:    
• Stress (oxidative stress) regulation under hyperglycemic condition that leads 
to cardiac dysfunction, by using melatonin as an antioxidant  
• Estimation of serotonin induced pathological changes in diabetic rat heart 
that leads to cardiac hypertrophy  
• Stress estimation and measurement in TAC and transgenic model (CnA-Tg,  
Tg-miR-119, Tg-MI)  
• To investigate the antioxidants enzymes mRNA as well as post translationa l 
level expression under stress condition using experimental animal model  
• In vitro analysis of stress regulatory (antioxidants enzymes) mechanism 
using neonatal rats cardio myocytes primary cell culture and HL-1 cell line  
• Stress regulatory pathways study during ISO and ET-1 induced 
hypertrophic condition  
• miRNAs expression under stress (TAC, CnA-Tg, H2O2 treated HL-1 cells, 
ISO)   
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Part 1.2: Stress regulation in hematopathologies   
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Different hematopatholgies including blood cancer are presently investigated but main 
focus was on leukemia and hematotoxicity. Following is the brief introduction of different 
hematapathologies and their link with present study.  
 1.2.1. Biology of leukemia   
Leukemia is a condition when hematopoietic stem cells are not able to differentia te (Molica 
et al., 2004; Sinnett et al., 2006). A common pluripotent stem cell, the ultimate source of 
cell lineage, by the process of hematopoiesis generates entirely different cell lineage that 
forms blood as well as immune system. The self-renewal and differentiation of 
hemetopoietic stem cell is maintained (Huntly and Gilliland, 2005) with the help of various 
factors such as hormones and growth factors (Lubbert et al., 2008). In leukemic condition, 
the leukemia cells are produced which are characterized by abnormal morphology, surface 
markers, genetics, epigenetics as well as deregulated cellular proliferation mechanism 
(Chaudhury et al., 2015; Dick, 2008).  
 Leukemia is categorized according to the development of disease either acute or chronic 
(Fieke et al., 2010). Annually, with 2.8 % of overall cancers cases reported (300,000 new 
cases and 220,000 deaths) leukemia is common among the worldwide hematologica l 
malignancies (Hoglund et al., 2015; Parkin et al., 2005)   
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1.2.2. Types of leukemia   
Mainly leukemia has two major types, acute leukemia in which means disease developes 
and progresses quickly and chronic leukemia means disease and progress without 
treatment. Subtype of leukemia depends upon the stem cells that developed in the bone 
marrow. When leukemia developes from myeloid stem cells it is called myeloid leukemia 
and if it is originated from lymphoid stem cells then leukemia is lymphoid or lymphoblas t ic 
(Bleakley  et al., 2015; Lubbert et al., 2008).  
 i.  Acute Lymphoblastic Leukemia   
Acute lymphoblastic leukemia (ALL) is a heterogeneous condition in which the leukemic 
cells arise from lymphatic progenitors in bone marrow or lymphatic system.  
Its diagnosis is based on morphology, cytochemistry of the cell in the bone marrow, 
immunological markers identification, and molecular genetics. ALL is more common in 
children while in adults ALL incidences are less frequent (Soulier et al., 2015; Moriyama 
et al., 2015; Dieter and Nicola, 2000).  
ii.  Acute myeloid leukemia  
In acute myeloid leukemia the malignant cells arise, accumulate and proliferate in bone 
marrow from myeloid progenitor that leads to hematopoietic failure. Like ALL, diagnosis 
is based on cellular morphology and immunologic, cytogenetic, and molecular feature of 
myeloid cells (Estey and Dohner, 2000). AML is the most common type of leukemia in 
adults and its incidence increase with age. It mostly targets people between ages of 65 to 
75 (Deschler and Lubbert, 2006).  
1.2.3. Risk factors of Leukemia  
Risk factors for leukemia are both genetic and environmental comprising of benzene, high 
doses of ionizing radiation, chemotherapeutics, electromagnetic fields and life style etc.  
i. Genetic Factors   
Recently, Shah et al (2013) reported a novel link between genetics and leukemia especially 
B-ALL. Increased risk of childhood leukemia has recently been associated with Genetic 
polymorphisms that disrupt the host abilities to properly metabolize and transport 
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xenobiotic exposures (Canalle et al., 2004). In addition, the genetic polymorphism of 
carcinogenic encoding genes also affects the risk of relapse in patients therefore it 
considered being helpful in the diagnosis and prediction of the diseases including leukemia 
(Krajinovic et al., 2001).   
ii. Environmental Factors   
 Chemicals such as benzene exposure, high dose of radiation and chemotherapeutic agents 
are considered the main environmental factors for leukemia. Ionizing radiation is one of 
the risk factors and has causal relationship to leukemia such as AML, ALL and CML but 
not CLL (Mahoney et al., 2004). During diagnosis, X-rays exposure in postnatal period is 
the risk factor for leukemia as reported in previous studies (Shu et al., 2002). In addition to 
these factors a small association of non-ionizing radiation such as EMFs (electromagne tic 
field) to leukemia has also been reported (Greenland et al., 2000).  
 iii. Lifestyle related risk factors    
Lifestyle related risks are smoking, obesity and dietary intake of substances responsible for 
development of leukemia because these substances contain some leukemia causing agents 
e.g. benzene present in soft drinks due to decarboxylation of benzoic acid etc (Siegel, 1993). 
Although, smoking as a causal factor for leukemia (AML) has yet to be identified. However 
it is considered as a risk factor for leukemia, because tobacco smoke is composed of two 
of the three known occupational or environmental leukemogens and benzene. It has been 
reported that in the urine of smoker’s the benzene concentration is higher than non-smokers 
(Ong, 1994).  
Dietary factors are also related to the etiology and prevention of cancer. In dietary products, 
fruits and vegetables contain numerous bioactive and potentially anticarcinogenic 
substances that might inhibit the process of carcinogenesis (Steinmetz and Potter, 1996). 
Further, risk can be reduced with increasing the consumption of raw vegetables. In contrast, 
it has also been reported that milk, poultry and soft drinks may possible increase the risk of 
leukemia (Kwiatkowsk, 1993).   
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1.2.4. Interplay of ROS and antioxidants in Leukemia (acute myeloid and 
lymphoblastic leukemia)  
Elevated ROS production and oxidative DNA damage were observed in AML expressing 
mutants, N-Ras and B-cell CLL/lymphoma-2 (Bcl-2) (Rassool et al., 2007), showing that 
there is an evidence of increased ROS and oxidative stress in models of AML and also in 
primary AML samples. In patient studies, ROS production by resting and stimulated 
leukocytes was increased in samples from AML patients compared with leukocytes from 
healthy individuals, (Kato et al., 2003; Er et al., 2007), whereas another study detected an 
increased expression of oxidative stress response genes in AML patient samples (Bowen et 
al., 2003)  
ROS elevation in the leukemia cells (myeloid leukemia) cause two types of effects 
including, nonspecific oxidative damage to biomolecules and secondly hyperactivation of 
ROS signaling pathways, particularly pro-proliferative and survival pathways. For 
instance, IL-3 mediates Nox2 cytosolic sub-unit p47phox synthesis which in turn 
participates in free radical generation. Thus, apoptosis stimulated by Nox2 inhibitors via 
ROS regulation indicates that IL-3 induced ROS via Nox2 play a key role in leukemic cells 
protection from death (Maraldi et al., 2009).  Moreover, along with free radical generation 
the antioxidant activities were increased which proposed oxidative stress existence in 
leukemic conditions (Gilber et al., 1984).   
The misbalancing (oxidative stress) effect of ROS is balanced by the antioxidant action of 
enzymatic antioxidants. Antioxidant defenses including glutathione, thioredoxin, 
glutaredoxin systems (Kwon et al., 2003) are very important as they are involved in direct 
free radical elimination (pro-oxidants), serving a protective role for biological sites (Valko 
et al., 2006). The three best understood mechanisms of H2O2 regulation are via the actions 
of catalase, the glutathione system, and the peroxiredoxin (Prx) system. Catalase has one 
of the fastest turnover rates and efficiently catalyzes the conversion of two molecules of 
H2O2 to diatomic oxygen and two water molecules. However, catalase expression is usually 
restricted to peroxisomes in mammalian cells; therefore, H2O2 destruction in the cytosol is 
mainly achieved through the actions of glutathione peroxidase as part of the glutathione 
(GSH) system, and the Prx system (Komatsu and Obata, 2003).  
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Superoxide dismutase (SOD) is the main enzyme responsible for eliminating superoxide 
before it can participate in the formation of other ROS and is therefore a key line of defense 
against oxidative stress (Bannister et al., 1987). In leukemia cells, inhibition of SODs 
causes the accumulation of O-2 and led to free radicals induced apoptosis (Huang et al., 
2000). Further, SOD levels were reduced in patients of acute lymphoblastic leukemia both 
in just diagnosed and treated groups. This shows that imbalance leading to oxidative stress 
could be created due to free radicals in ALL patients (Oltra et al., 2001).    
1.2.5. Pro and anti-oxidative role of trace elements    
Trace elements have a significant role in a wide variety of biological processes such as 
activation or inhibition of enzymatic reactions, regulation of metalloproteins and cellular 
membrane permeability (Geraki and Farquharson, 2001). The human serum level of trace 
elements can be considered as an indicator of several pathological conditions and these 
elements may contribute to diagnosis and treatment of various diseases (Canellas et al., 
20006).  
Metal ions homeostasis is tightly regulated through uptake, storage and secretion processes 
and is vital for biological functioning (Bertini and Cavallaro, 2008). Redox homeostasis is 
maintained by metal homeostasis through cycling of redox active metals that participate in 
the transfer of electrons between metals and substrate (Lindeque et al., 2010). Conversely, 
disturbance in this homeostasis may contribute to oxidative stress via free radicals 
generation.   
Well known redox active metals including iron, cobalt and copper have the capacity to 
generate ROS undergoing redox cycling reaction (Jomova and Valko, 2011). Copper can 
induce oxidative stress via a Fenton-like reaction (Prousek, 2007) as well as through 
reduced antioxidants levels (Speisky et al., 2009).  Other elements such as Magnesium 
(Mn) and Zinc (Zn) are essential components of several endogenous antioxidant enzymes. 
Inactivation of these antioxidants by unavailability or deficiency of trace elements 
generates free radicals that have been suggested to contribute in carcinogenesis (Daniel et 
al., 2004). Antioxidants (enzymes) such as SOD, CAT and GSH work together and require 
metals e.g. Zn (ZnSOD), Cu (CuSOD), Mn (MnSOD) and Se as cofactors to eliminate ROS 
(Mates et al., 1999). NiSOD has been recently described as being an important antioxidant 
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enzyme (Krause et al., 2010). It is suggested that elevated level of Ni in serum may also 
play a significant role in leukemia (Wen et al., 1989).  
1.2.6. Role of oxidative stress and its regulation in hematotoxicity  
Hematotoxicity is defined as significant arbitrary decrease or increase in more than one 
type of blood cells (Zhang et al., 2010). Hematotoxicity is a commonly observed side effect 
of many antiviral therapeutics and most commonly observed condition is aplastic anemia 
(Sun, 2014). Radiation therapy also causes immunodeficiency due to its cytotoxic effects 
on peripheral blood cells and bone marrow cells (Heylmann et al., 2014). Hematotoxic ity 
also covers some other blood disorders including leukopenia, neutropenia and 
thrombocytopenia (Pyatt et al., 2000). Hyperactive proliferation of pluripotent hemopoiet ic 
stem cells (CFU-S) is common side effect of some cytostatic drugs. Continued 
administration of these medicines may cause acute imbalance in hemopoiesis (Metcalf, 
2010). Xenobiotics adversely affect hematopoiesis and may cause bone marrow failure 
leading to myelotoxicity and other hematological disorders. These failures of bone marrow 
cause reduction in mature circulating blood cells (Davila et al., 2004). Exposure to 
environmental toxicants such as polychlorinated biphenyls, polycyclic aromatic 
hydrocarbons, benzene and other phenols is major causes of increased susceptibility to 
develop hematological disorders.  
ROS have a pivotal role in signal transduction but in excess they can contribute to fetal 
toxicity by deregulation of signal transduction and/or by oxidative damage to cellular 
macromolecules such as lipids, proteins, DNA, and RNA. Oxidative stress can lead to a 
number of human diseases including different types of cancers (Kukic et al., 2006; Sinenko 
et al., 2010). Wan and Winn (2008) have reported that ROS play a major role in benzene-
mediated fetal hematotoxicity in mice. Antioxidants are the key performers when it comes 
to deal with the devastating effects of free radicals and reactive oxygen species (ROS) on 
typical cell physiology. However, production of antioxidants is itself synchronized with the 
oxidative stress levels in cell (Rodriguez et al., 2004).  Levels of oxidative stress are 
maintained by the enzymatic or nonenzymatic antioxidants counting vitamins and 
detoxifying enzymes including superoxide dismutase (SOD), catalase (CAT), peroxide 
dismutase (POD) and glutathione reductase (GSH) which are responsible for neutralizing 
these reactive entities (Soyinka et al., 2007).  
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Bunium persicum is a rich source of essential oils including terpenoids and alkaloids with 
different biological activities like antioxidant and antimicrobial effects (Sharififar et al., 
2010). Essential oils found in B. persicum have antifungal activity (Sardari et al., 1998) and 
antimicrobial activity (Oroojalian et al., 2010). Seed of B. persicum is rich in phenolic 
compounds and γ-terpinene which exhibit potential antioxidant activities and can act as 
efficient free radical scavengers (Shahsavari et al., 2008). On the basis of strong 
antioxidative potential of B. persicum, we employed its extract to check its anti-  
hematotoxic activity. Further being a mild spice its consumption would not be hazardous 
to normal metabolic functions of body.  
1.2.7. Aim and objective:  
The aim of this study is to highlight the role of oxidative stress during hematopathologica l 
conditions. The specific goals of the study are mentioned below:   
• Investigation of ROS level and SOD activity in acute leukemia  
• Redox active trace elements (Fe, Zn, Cu and Ni) concentration measurement 
in the serum of leukemia patients from the Pakistani population  
• Estimation and regulation of free radicals in the fresh leukemia induced 
hematoxicity   
• Anti-hematotoxic role of the B. persicum, seeds extracts  
  
 
 
 
 
 
Material Methods   
The present research is performed in “Signal Transduction lab, Department of 
Biochemistry, Quaid-e-Azam University, Islamabad and in “Centre for molecula r 
cardiology, department of cardiology, CARIM school for the cardiovascular diseases, 
Faculty of Health Medicine and Life Science, Maastricht, The Netherlands”.  
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2.1. Ethical consideration  
All animal procedures were, according to the standards documented in the “Guide for the 
Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National 
Academy of Sciences, Washington, DC; 1996) and approved by the ethical committee of 
Quaid-e-Azam University Islamabad, Pakistan as well as Maastricht University, Maastricht  
Netherlands. Studies on human samples complied with the ethical principles stated in the 
“Declaration of Helsinki”.  
2.2. Human patients samples used in the present study  
 i.  Diabetic patients   
In the present study, 80 patients suffering from diabetes mellitus and 50 healthy individua ls 
were subjected to investigation. Blood samples were collected from subjects followed 
serum separation (4000 RPM centrifugation). Serum samples were then stored at freezing 
temperature until analysis.   
ii.  Leukemia patient characteristics and blood sampling   
The present analysis was carried out on 60 acute leukemia (ALL, AML) subjects, under the 
patient's consent and approved by the Ethical Committee, oncology department of Pakistan 
Institute of Medical Sciences (PIMS).  Leukemia conditions were determined by 
morphological and cytochemical studies. The age limit for the acute lymphoblast leukemia 
was 20 years, and for acute myeloid leukemia there was no age limit. Serum of 30 healthy 
individuals was collected as a control group. The age of the control group ranged from 4 to 
56 years. Blood samples of leukemia patients as well as healthy subjects were collected 
from the oncology department of Pakistan Institute of Medical Science Islamabad (PIMS). 
Serum was extracted by centrifugation of blood at 4000 RPM for 10 minutes.  
2.3. Animal Models  
i. Hyperglycemia induction in rats  
Hyperglycemia was induced in experimental animal model (weighting 120g-160g) through 
alloxan (Intraperitoneal, i.p) as well as oral glucose administration. The other treatments 
were administrated according to the scheduled plan, as shown in table 2.1.  
All the baseline characteristic were measured at different stages of the experiment.  Table  
2.1: Treatment schedule of hyperglycemic rat model  
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Groups   Treatment   
Alloxan   A single i.p injection of alloxan 140 mg/kg + Oral glucose  
Alloxan + Melatonin  140 mg/kg + 10mg/kg/day/rat for 15 days  
Melatonin  10 mg/kg/rat  
Normal control  Equal volume of normal saline for due days  
  
ii. Serotonin administrated diabetic rat model  
The study was composed of four groups of Sprague-Dawley rats (n = 5 each group) 
(weighing between 180g-200g). The experimental animals were treated according to plan, 
schedule, as shown in table 2.2.   
Body weights and blood glucose levels of rats were measured before treatment of drugs 
(Alloxan, serotonin), after treatment and at the end of the experiment. After 10 days all rats 
were dissected, blood was collected in coagulant gel tube. Serum was then separated as 
supernatant from cells by centrifugation for 10 minutes at 4000 RPM. The hearts were 
excised and stored in liquid nitrogen followed by storage at -80 ᴼC as well as in formalin 
for further analysis. iii. Endothlin-1 administrated rats  
Endothelin-1 is a well-known stress inducer and previously used for cardiac hypertrophy 
induction in animal models. To measure stress (oxidative stress) in hypertrophic conditions, 
twenty-four neonatal rats of 2-3 days were obtained from the Animal House of the 
Department of Biological Sciences, Quaid-I-Azam University, Islamabad, Pakistan, and 
randomly divided into six groups followed by drug administration (Table 2.3).  
  
Table 2.2: Drug schedule of serotonin treated diabetic rats   
Groups   Treatment   
 
Alloxan + Serotonin  A single i.p injection of alloxan 120 mg + 60mg/kg/day  
 
Serotonin  60 mg/kg/day/rat    
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Alloxan  120 mg/kg  
 
Normal control  Equal volume of normal saline for due days  
 
  
  
Table 2.3: Endothlin-1 i 
nduced hypertrophic model drug treatment schedule  
 
Groups  Treatment    
ET-1  100  µg/kg/day/rat  was  administrated  to 
 induce hypertrophy  
cardiac  
ET-1+ NAC  100 µg + 50 mg/kg/day/rat were administrated   
 
ET-1+ Melatonin  100 µg + 2.5 mg/kg/day/rat   
 
NAC  50 mg/kg/day/rat   
Melatonin  2.5 mg/kg/day/rat   
Normal saline  Equal volume of drug for due days    
  
iv. Isoproterenol administrated rats    
Isoproterenol (ISO) is a potent inducer of cardiac pathologies and is used for animal cardiac 
disease modeling. To determine and measured ISO induced oxidative stress and  deleterious 
effects on heart tissues, animal (rats) were grouped and administrated according to design 
experimental schedule (Table 2.4).  
  
v. Calcineurin transgenic mice (CnA-Tg)  
Calcineurin transgenic mice (8 week old, female) were used in the current investigat ion. 
These transgenic mice express activated calcineurin (mutated form) in the postnatal heart 
which is regulated by 5.5-kb murine myh6 promoter (MHC-CnA).  
The transgenic mice were developed as described (DA et al., 2010).   
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Table 2.4: Isoproterenol (ISO) induced hypertrophic animal model drug treatment schedule    
Groups  Treatment   
Isoproterenol   5 mg/kg/day/rat was administrated to induce cardiac 
hypertrophy  
Isoproterenol + NAC  5 mg + 50 mg/kg/day/rat were administrated   
Isoproterenol + Melatonin  5 mg + 5 mg/kg/day/rat   
NAC  5 mg/kg/day/rat  
Melatonin  5 mg/kg/day/rat    
Normal saline  Equal volume of drug for due days   
  
vi. Transverse aortic constriction and sham   
Following previously described protocol “transverse aortic constriction (TAC) or sham was 
carried out in 2-month-old mice. A 27-gauge constriction in the aorta was developed 
between the first and second truncus of the aortic arch (Rockman et al., 1991).  Mice were 
lightly anesthetized using isoflurane (mean 1% in oxygen), shaved and after then Doppler-
echocardiography was performed. Digital cardiac ultrasound platform (SONOS 5500, 
Philips) with a 15-MHz linear scanner (M- and B-mode) was used which calculates non-
invasive, echocardiographic parameters. To measure the pressure gradient between 
proximal and distal sites a 12-MHz short focal lengthphased array transducer (pw- and cw-
Doppler) was applied to the chest wall” (Da costa et al., 2008). Mice with >50 mm pressure 
gradient were only included in the present study.   
2.4. Cardio myocytes culturing and treatment   
 i.  Isolation and culturing  
Wister rats of 1 to 2 days were used for primary cell culturing. According to previously 
described protocols (Harsdorf et al., 1999; Li et al., 2009) cardiomyocytes were isolated 
after dissection and mincing heart tissues in buffer (N-2hydroxyethylpiperazine-N'-2-
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ethanesulfonic acid buffered saline solution containing (in mM): NaCl, KCl, NaH2PO4, 
glucose and HEPES in the ratio 130: 3:1: 4: 20 (pH 7.35). Cardiac tissues were then 
subjected to HEPES buffered saline solution containing 1.2 mg/ml pancreatic and 0.14 
mg/ml collagenase (Worthington) incubations (series) at 37 ºC and centrifugation. The cells 
were then resuspended in  
Dulbecco’s modified Eagle’s medium/F-12 (GIBCO) containing 5% heat inactivated horse 
serum, 0.1 mm ascorbate, insulin transferring sodium Selenite media supplement, 100 U/ml 
penicillin, 100 µg/ml streptomycin and 0.1 mM bromodeoxyuridine (BrdU). After 
incubation of 1hr at 37 ºC the pre-plated cells were diluted to 1x106 cells/ml. The freely 
suspended myocytes were separated from cell suspension whereas the non-myocytes 
remain attached to the surface. According to our experimental requirement cells were plated 
in different culture dishes coated with laminin (10 µg/ml). After 24 hrs the medium was 
replaced by serum free medium. ii. Treatment of cardiomyocytes with ET-1 and PE  
Phenylephrine (PE) and Endothelin-1 (ET-1) both are used for a long time for the induction 
of cardiomyocytes hypertrophy. Cultured cardiomyocytes were treated with PE (10 µM) 
and ET-1 (100 nM) for 24 hours as well as for 48 hours to induce hypertrophy. After due 
time the treatment was stopped and cells were collected for downstream experiments.   
iii.  HL-1 cell treatment with H2O2  
HL-1 cells are cardiac muscle cells having proliferative characteristics. To determine the 
effects of free radical (H2O2) on heart tissues, HL-1 cells were cultured and treated for 8 
hours with different concentrations (0 µM, 50 µM, 100 µM) of H2O2. After due time the 
treatments were blocked and cells were collected and processed for further analysis.   
2.5. Micro RNA, selection, extraction and expression  
 i.  Prediction of MicroRNA targets   
To determine and predict the selected MicroRNAs putative targets, different databases and 
tools including miRBase “(http://microrna.sanger.ac.uk/), PicTar (http://pictar.mdc -
berlin.de/) and TargetScan (http://targetscan.org/index.html)” were used. List of 
miRNAs was shown in table 2.5.   
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Table 2.5. Primer sequences of the studied miRNAs   
MicroRNAs   Primer sequence  
miR-152  5’-TCAGTGCATGACAGAACTTGG  
miR-142-3p  5’-TGTAGTGTTTCCTACTTTATGGA  
miR-206  5’-TGGAATGTAAGGAAGTGTGTGG  
miR-205  5’-TCCTTCATTCCACCGGAGTCTGT  
miR-139-5p  5’-TCTACAGTGCACGTGTCTCCA  
miR-132  5’-TAACAGTCTACAGCCATGGTCG  
miR-199b  5’-CCCAGTGTTTAGACTATCTGTTC  
miR-155  5’-TTAATGCTAATCGTGATAGGGGT  
miR-17  5’-CAAAGTGCTTACAGTGCAGGTAG   
Universal Rev  5’-GAATCGAGCACCAGTTACGC  
 
ii.  Isolation/extraction of RNA from mouse tissue   
Trizol reagent (Invitrogen) was used for the extraction of total RNA as previously 
described. Tissues were homogenized in 1ml of Trizol reagent and after gentle vortexes, 
homogenates were collected in 2 ml tubes. After allowing the samples to stand on the bench 
top at RT for 5 min to promote dissociation of nucleoprotein complexes, 0.25 mL (250 µL) 
chloroform was then added and the tubes were further vortexed for 15 sec. Following a 
further incubation at RT for 2-3 minutes, the samples were centrifuged at 5000 rpm (at 4 
°C) for 25 min. Centrifugation will separate three phases, an upper, colorless phase 
containing total RNA, a white interphase containing DNA and a lower pink phase 
containing organic chemicals and proteins.   
The upper water phase (colorless) was collected and transferred to fresh nuclease free 1.5 
ml microcentrifuge tubes and 1.5mL of isopropanol to each tube (always be 1.5X of the 
amount of Trizol used). The tubes were then incubated at -80 ºC for two hours (or overnight 
at -20 ºC). The incubated mixture was then centrifuged for 10 minutes at maximum speed 
at 4 ºC. The upper phase (supernatant) was discarded and RNA pellet was washed three 
times by adding 0.5 ml of 70% ethanol. The supernatant was removed and dried at room 
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temperature for about 30 minutes. Finally, 25 µl of water (MQ) was added to each tube and 
mixed well via pipetting up and down. RNA quantification (in ng/µl) was performed using 
the UV/VIS NanoDrop-1000™ spectrophotometer (Nanodrop, V3.7, Thermo Fisher 
Scientific), and absorption was taken at wavelength of 260 nm (A260) and 280 nm (A280) 
using RNase free water as a control. RNA absorption is proportional to the concentration 
at A260, “where 1.0 A260 unit equals 40 µg/ml RNA”. An A260/A280 ratio above 1.6 was 
considered adequate. RNA samples were stored at -80 °C in RNase free tubes.  
iii.  cDNA synthesis for micro RNA  
Using the instructions provided with the kit (the miScript Reverse Transcription Kit 
(Qiagen) cDNA were synthesized. RNA (1µg) with standard quantification was diluted in 
15ml water (MQ) followed by the addition of 4 µl of buffer and 1µl of enzyme. The mixture 
was subjected to incubation for 1hr (at 37 °C) and finally heated at 95 °C to inactivate the 
enzymes.   
iv.  Conventional cDNA synthesis from cultured cells  
The cDNA synthesis was performed following the instructions given with kits (miScript 
Reverse Transcription Kit (Qiagen)). Quantified RNA (1µg) extracted from cultured cells 
with standard ratios were diluted in 14 µL water. Then 1ul of oligo (dT) primer and 1µl of 
hexamer were added and mixtures were incubated at 70 ºC for 5 minutes. After chilling the 
mixture on ice, 5 µl of 5x RT buffer, 2.5 µl of dNTPs  
(10mM), 0.5 µL of RNAsin, and 1ul of MMLV enzyme were added and incubated for 60 
minutes at 40 ºC. Finally this mixture was heated at 70 ºC for 15 minutes to inactivate the 
enzymes and later chilled on ice and stored at -20 ºC.   
 2.6. Quantitative real time PCR   
i. Stress markers (ANF, Acta-1, myh-7, Rcan1-4) and SOD1, SOD2 and CAT.  
RNA (1 µg) from cultured treated cells and experimental cardiac tissues was reversed 
transcribed via “Superscript II reverse transcriptase” (Invitrogen). Relative expression of 
gene was identified through Quantitative real time on PCR BioRad iCycler (Biorad) with 
cyber green. Using relative Ct method (“where the amount of target normalized to the 
amount of endogenous control (L7) and relative to the control sample is given by 2–ΔΔCt”), 
and transcript quantities were determined.    
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Table 2.6. Forward and reverse primer sequences  
Genes    Forward Primers  Reversed Primers   
myh7(r)  5′-CGGACCTTGGAAGACCAGAT  5′-GACAGCTCCCCATTCTCTGT  
acta1(r)  5′-CCGGGAGAAGATGACTCAAA  5′-GTAGTACGGCCGGAAGCATA  
ANF (r)  
5’-GGTAGGATTGACAGGATTGGAG  5’-TTGGCTGTTATCTTCGGTACC       
rcan1-4 (r)  5′-GCTTGACTGAGAGAGCGAGTC  5′-CCACACAAGCAATCAGGGAGC  
L7 (r)  5′-GAAGCTCATCTATGAGAAGGC  5′-AAGACGAAGGAGCTGCAGAAC  
BNP (r)  
5’-GAACAATCCACGATGCAGAAG  5’-TCTTTTGTAGGGCCTTGGTC    
SOD1 (r)  5’-CCTGGGCAAAGGTGGAAATG  5’-GACTCAGACCACATAGGGAATG  
SOD1 (m)  5’-CTCAGGAGAGCATTCCATCATT  5’-CTCCCAGCATTTCCAGTCTT  
SOD2 (r)  5’-CCATTCAGCCCCATGAATTG  5’-CTGAAGACACCCTACTGACC  
CAT (r)  5’-GATGGTAACTGGGATCTTGTGG  5’-GTGGGTTTCTCTGGCTATG  
CAT (m)  5’-GTACAACTCCCAGAAGCCTAAG  5’-ACCCGTGCTTTACAGGTTAG  
Nox4 (r)  5’ AGTCAAACAGATGGGATA  5’ TGTCCCATATGAGTTGTT  
ii.  miRNA detection by QPCR  
RNA was isolated with Trizol reagent (Invirogen). cDNA was synthesized with the  
“miScript Reverse Transcription Kit (Qiagen)”.  miRNAs were detected on BioRad iCycler 
(Biorad) with cyber green using primers shown in table 2.5. Using Ct relative method 
miRNA concentration was quantified and amount was normalized to the amount of U6.   
2.7. Western blotting   
Stress markers as well as transcription factors post translational regulation was analyzed by 
immunobloting. Protein samples were separated via SDS-PAGE and transferred onto 
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nitrocellulose membranes (pore size 0.45 µm, Santa Cruz Biotechnology) at 100 V for 120 
minutes in transfer buffer (20% methyl alcohol, pH 8.3, 192 mM glycine, and 25 mM Tris) 
following standard protocols. The membrane was blocked with Non-fat milk to avoid 
nonspecific binding, followed by primary antibody (1:500) overnight incubation at 4 °C. 
The next day membrane was treated with secondary antibody (goat anti-rabbit antibody 
IgG-AP 1:2,000) for 1hr at 4 °C followed by alkaline phosphtase treatment (1X AP reaction 
buffer 50 µl of NBT and BCIP from Tiangen, Beijing, China). For detection the ECL Super 
signal chemiluminescence kit (Pierce) was used according to manufactures protocol to 
subsequently visualize blotted products in LAS 3000 (Fuij Film).  
Table 2.7. Antibodies used in the present study   
Primery Antibody  Dilution Used  Company  
ANP  1 in1000  Santa Cruz biotechnology, Dallas, Texas  
BNP  1 in 1000  Santa Cruz biotechnology, Dallas, Texas  
GATA 4  1 in 1000  Santa Cruz biotechnology, Dallas, Texas  
SOD2  1 in 1000  Santa Cruz biotechnology, Dallas, Texas  
CAT  1 in 1000  Santa Cruz biotechnology, Dallas, Texas  
NFAT3c  1 in 1000  Santa Cruz biotechnology, Dallas, Texas  
CK2  1 in 1000  Santa Cruz biotechnology, Dallas, Texas  
GAPDH  1 in 1000  Santa Cruz biotechnology, Dallas, Texas  
  
2.8.  Plant materials  
Plant materials (seeds) were purchased from a market in Rawalpindi, Pakistan. They were 
cleaned, washed, and dried under the shade. The seeds were then ground into fine powder 
with a grinder.  
i. Preparation of crude extract and fractionation  
The procedure described by Wube et al. (2005) was followed for extraction. Briefly, the 
powdered residue (3 kg) was kept in a closed container and extracted with methanol by 
maceration for 4 days to obtain the crude extract (175 g). The solvent containing the crude 
extract was filtered with a Whatman filter paper (Number 1) and evaporated under reduced 
pressure using a rotary evaporator and allowed to dry at room temperature. The maceration 
process was repeated three times. The dried extract obtained was suspended in water and 
extracted with hexane, ethyl acetate, and butanol solvents subsequently using a separating 
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funnel to obtain the ethyl acetate, butanol, hexane, and aqueous fractions. The solvent from 
each fraction was evaporated and allowed to dry. The dried fractions were kept at -2 ºC in 
dark glass bottles for experimentation.  
ii. Experimental design and treatment  
 After the 40th day of injection (free blood of leukemia patient) , the weight of each rat was 
accurately measured, and rats were treated as follows: Group A, 300 mg/kg/d aqueous 
fraction in 0.5 mL Tween; Group B, 300 mg/kg/d butanol fraction in 0.5 mL Tween; Group 
C, 0.5 mL/d of 5% Tween; Group D, normal with leukemic blood treated, 0.5 mL/d of 5% 
Tween; Group H, 300 mg/kg/d hexane fraction in 0.5 mL Tween; Group E, 300 mg/kg/d 
of rat body weight ethyl acetate fraction in 0.5 mL Tween. The dosages were given as i.p. 
injections for 9 consecutive days. Table 2.8 shows the treatment schedule.  
iii. Collection of bone marrow  
The bone marrow was collected from both tibia and femur within hours after the rats were 
sacrificed. The bones were cleaned from the tissue, and the tips of each bone was cut down 
from one side and flushed out from the other side with 25-gauge needle with phosphate 
buffer saline into a falcon tube. The flushing was repeated several times until the bone 
turned pale. The filtrate was centrifuged at 1000 rpm for 10 minutes, and the supernatant 
was discarded. The fixative (1:3) acetic alcohol was added to the falcon tube and was gently 
mixed then centrifuged again to obtain a fresh cell button end; next, fresh fixative was 
added to obtain cell suspension. A drop was placed from the cell suspension into a clear 
slide and allowed to dry. The air-dried smears of bone marrow aspirate were fixed in 
methanol for 8 minutes. The slides were then immersed in Giemsa stain for 10 minutes and 
washed with distilled water to remove the extra stain. Slides were observed under a light 
microscope (Meiji Techno MT6200) at 100X magnification.  
  
Table 2.8: Treatment schedule   
Groups  Treatment  
A  Injected with leukemic blood; treated with aqueous fraction  
B  Injected with leukemic blood; treated with butanol fraction  
C  Designated as control group (normal); treated with 0.5 mL of 5% Tween  
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D   Assigned as disease control group; injected with leukemic blood and 
treated with 0.5 mL of 5% Tween  
E  Injected with leukemic blood; treated with ethyl acetate fraction  
H  Injected with leukemic blood; treated with hexane fraction  
  
  
2.9. Biochemical assays  
 i.  Reagents.  
All the chemicals used were commercially available. N,N-diethyl-peraphenylened iam 
DEPPD (Fluka analytical), 0.1M sodium acetate buffer (pH 4.8) (VWR international Ltd) 
ferrous sulfate (Sigma Aldrich), Phosphate Buffer (pH 5.5) and H2O2.  All chemicals used 
were of analytical grade ii. Measurement of serum/homogenate free radicals  
Serum free radicals status was analyzed by previously developed method (Hayashi et al., 
2006). Briefly, R1 (solution as chromogen) was prepared by dissolving DEPPD (N,N-
diethyl-paraphenylendiamine) in 0.1M sodium acetate buffer to get final concentration of 
100 µg/ml. Reagent (R2, as a transition metal ion) of final concentration 4.37 µM was 
prepared by dissolving ferrous sulfate in 0.1M sodium acetate buffer (pH 4.8). By gently 
mixing R1 and R2, at a ratio of 1:25 working solution was prepared. Hydrogen peroxide 
(60 µl) was added as a positive control.  
For further sample analysis, instead of hydrogen peroxide serum samples were used for 
ROS detection. After free incubation of one minute, absorbance at 505 nm was observed 
using Agilent 8453 UV-Visible Spectrophotometer (U.K) iii. SOD activity detection 
assay  
Serum activity of SOD was measured as described (Wayne et al., 1987). Reaction mixture 
was prepared by taking PBS buffer (NaCl, KH2PO4, Na2HPO4 and KCl), Lmethionine, 
NBT (Nitro blue Tetrazolium) and Triton X-100 followed by the addition of sample. After 
illumination with fluorescent lamp riboflavin was added to initiate the reaction. Sample 
mixture was delivered into cuvettes and measurement was taken at 560 nm. Control sample 
without serum was also run in parallel.  
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iv.  CAT activity detection assay  
Serum catalase level was measured using H2O2 as a substrate (Aebi et al., 1974). 
Serum/tissue extract of 0.1 ml was added to 0.4 ml H2O2 in 2.5 ml of phosphate buffer (pH 
7.8) and degradation of H2O2 was immediately measured at 240 nm for 60 seconds. The 
difference in the level of absorbance was used to calculate enzyme activity of catalase and 
the activity was represented as units/minute. (One unit is described as a difference of 0.01 
in O.Ds taken at the interval of one minute).    
v.  TBARS (Thiobarbituric Acid Reactive Substances) Analysis  
The method of TBARS assay was described by Buege and Austin, 1978. TBARS level was 
estimated to determine the damage to lipids caused by reactive oxygen species in various 
experimental groups. Briefly, 0.1 ml of sample, 0.1 ml FeSO4, 0.1 ml Tris-HCl, 0.6 ml 
distilled water and 0.1 ml Ascorbic Acid were incubated at 37 °C in test tube for 15 minutes 
and then 1 ml TCA and 2 ml TBA were added. These plugged test-tubes were incubated 
for 15 minutes at 100 °C followed by centrifugation at 3000 rpm for 10 minutes. The 
supernatant O.D. was determined at 532 nm and following formula was applied to estimate 
TBARS as nM/mg protein:   
TBARS (nM/mg protein) = O.D × Total volume× Sample volume × 1.56 × 105 × mg 
protein/ml  
[1.56 × 105 = Molar Extinction Coefficient]  
vi.  Lipid Profiling  
The lipids including LDL, HDL, TG, and TC were profiled through AMP Diagnostic kit, 
Austria. The kit manufacturer's instructions were strictly followed while performing all the 
biochemical assays.  
2.10. Histological analysis   
Formalin-fixed, paraffin embedded specimens were cut into 3 µm sections followed by 
hematoxylin-eosin staining for morphological evaluation. Sections were then observed 
under polarized light and bright field microscope of different magnifications. Cell surface 
areas (from slides developed for histological studies) were measured by SPOT camw 4.0.  
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2.11. Elements concentration measurement   
 Trace elements (Fe, Zn, Cu and Ni) were analyzed by Varian fast sequential atomic 
absorption spectrophotometer (AA240FS) using instrumental standard protocols.  
2.12. Statistical analysis  
Data was analyzed by SPSS 21. To evaluate significant difference among the group 
different statistical tests including ANOVA followed by multiple comparison test such as 
Tukey’s, Student’s t-test, chi-square and Mann-Whiney were applied. All the data were 
presented as mean ± SD or SEM.  P values were considered statistically significant when 
less than 0.01 or 0.05.   
 
 
 
 
 
 
Part (1) 3.1: Stress as a regulatory factor in cardiac 
complication  
Study design and results   
Stress is known to be a critical player of several signaling events associated with 
different abnormalities. Herein, to determine the relation of stress and stress induced 
imbalance in cardiac pathologies, different stress inducers, such as hyperglycemia, 
endothelin-1 (ET-1), serotonin, phenylephrine (PE), and isoproterenol (ISO) were 
selected (Fig.  3.1). Imbalance of free radical and antioxidants, which leads to oxidative 
stress were analyzed and suggested to be involved in cardiac pathologies by regulat ing 
different signaling pathways. The effects of oxidative stress on antioxidants enzymes 
activities and expression as well as miRNA link to oxidative stress were measured and 
analyzed.   
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Figure 3.1: Flow sheet of the study  
3.1.1. Analysis of oxidative stress induced by hyperglycemia   
Oxidative stress is a key mediator and regulator of several complications includ ing 
hyperglycemia. As a result of unregulated free radical production the oxidative stress is 
generated. Hyperglycemia is one of the reported oxidative stress inducer. Herein we 
screened out hyperglycemia induced oxidative stress consequences while using 
melatonin as a free radical regulator.   
 i.  Baseline characteristics of hyperglycemic animal model  
The baseline characteristics of experimental model are summarized in table 3.1.  The 
average body weights at the start of the experiment, at the onset of diabetes in diseased 
groups and at the end of the experiment were measured. The body weights increased 
normally in normal saline as well as in melatonin treated animals. However, in diabetic 
as well as melatonin treated diabetic animal models decrease in body weights were 
observed, suggesting a relation of high glucose with body weights. High blood glucose 
levels are considered the major contributor in both, type 1 and type 2 diabetes. We 
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measured the blood glucose levels in different experimental groups before starting the 
experiment, in diseased condition and at the end of the experiment as shown in table 
3.1. The ratio between heart weights, tibia length and heart weights and body weights 
were also determined. There was no significant difference in both ratios (Fig.  3.2).   
  
Figure 3.2: The ratio between heart weight, body weight and tibia lengths. A: Hearts 
weight and body weight ratio, B: Heart and tibia length ratio. HG: Hyperglycemia. 
Tukey’s multiple comparison test was applied to measure the significance among the 
groups.  
Table 3.1: General characteristics of experimental model  
Groups   Initial  
body 
weights  
(g)  
Final 
body 
weights  
(g)  
Fasting 
Glucose 
levels   
Final  
Glucose  
level   
Heart 
weights  
(g)  
Tibia 
lengths 
(cm)  
Normal   134   169  121  123.7  0.575  3.77  
Hyperglycemic   150  141  117  472  0.633  3.76  
Hyperglycemic + Melatonin  126  118  122  421  0.55  3.3  
Melatonin  120  143  111  86  0.633  3.5  
P values  0.003  0.008  0.797  0.001  0.751  0.73  
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Data presented as group mean. P values (between the groups) calculated by ANOVA.  
ii.  Estimation of free radical in melatonin treated hyperglycemic rats   
A free radical is considered as the mediator of various redox signaling which plays a 
vital role in the molecular mechanism of several complications includ ing 
hyperglycemia. The ROS levels were measured in serum as well as in the heart tissues 
of all the experimental rats. A significant increase both in serum and tissue ROS level 
in the hyperglycemic animal model compared to normal control was observed, that 
shows the role of free radical in hyperglycemia. To know more about the ROS 
regulation in hyperglycemia we treated animal model with a potent antioxidant  
‘melatonin’ along with alloxan, a hyperglycemia inducer. We found a significant 
decrease in ROS levels, both in serum as well as in the heart tissues compared to the 
hyperglycemic rat model. These findings suggest a free radical role in hyperglycemia 
signaling (Fig. 3.3).   
iii.  Hyperglycemia induced imbalance in antioxidant enzyme activities  
To counterbalance the deleterious effects of free radicals, naturally human body 
possesses its defense system comprising of antioxidant enzymes. These antioxidants, 
including SOD and CAT play important role to eliminate these reactive species. In the 
present study, we measured SOD and CAT activities in hyperglycemia rat model while 
using melatonin as an antioxidant. The activites of antioxidants (SOD, CAT and POD) 
both in serum as well as at tissue level were significantly decreased in hyperglycemic 
rats compared to the control subjects. However, in the melatonin treated hyperglycemic 
rats antioxidants activities were recovered. (Fig. 3.4). These findings suggest the strong 
relation of free radicals to hyperglycemia.   
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Figure 3.3: ROS level status A: Comparative Serum ROS levels B: Comparative 
Heart tissue ROS levels. Graphs are representative of at least three experiments in 
triplicates. *: shows significant difference compared to the normal control. ANOVA 
posthoc Tukey’s multi. P value significant when less than 0.05. HG: Hyperglycemia  
  
Figure 3.4: Antioxidants activities in the experimental models. A and B: Serum and 
heart tissue homogenates SOD activities, respectively. C and D: serum and tissue 
catalase activities, respectively. E and F: Serum and heart tissue, POD activities, 
respectively. HG: Hyperglycemia. Graphs are representative of at least three 
experiments in triplicates. *: Shows significant difference compared to the saline 
treated group. P value was consider significant when less than 0.05.   
iv.  Heart tissue histology of melatonin treated hyperglycemic animal model  
To assess the role of free radical with heart tissues histological changes of the heart 
tissues, hematoxylin and eosin staining was performed. Sections were studied under a 
light microscope (DIALUX 20 EB) at 40X magnifications. Signs of apoptosis (with 
condensed and fragmented nuclei) were greater in the hyperglycemic animal model 
compared to the control subjects (Fig. 3.5).  
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Figure 3.5: Histological presentation of the experimental models. A and B: Normal 
saline treated, C and D: hyperglycemia, E and F: hyperglycemia + melatonin, G and 
H: melatonin treated rats heart tissues.    
v.  Lipid profiling  
To observe the metabolic and toxic consequences of treatment groups we estimated the 
level of liver function markers (AST and ALT) in the experimental models. Increasing 
trend was observed in the ALT level of hyperglycemic rat compared to the normal 
subjects. However, a decrease in ALT level was observed in melatonin treated 
hyperglycemic model. AST level in the case of hyperglycemia as well as melatonin 
treated hyperglycemia models decreased significantly compared to the control subjects. 
Similarly, serum cholesterol and triglycerides were significantly increased in 
hyperglycemic condition compared to the normal subjects. However, in melatonin 
treated hyperglycemic rats, both of these lipids were decreased compared to the 
hyperglycemic experimental models (Fig. 3.6). These findings suggest that melatonin 
may play a role as an antitoxic and anti-oxidative agent.   
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Figure 3.6: Serum cholesterol, triglycerides, AST and ALT level in melatonin treated 
hyperglycemia animal models. A: serum cholesterol level, B: Serum triglycerides, C: 
Serum AST level, D: Serum ALT level. *: Represent significant difference compared to 
the saline treated group and was considered significant when less than 0.05. HG:  
Hyperglycemia.   
3.1.2. Serotonin accelerates free radical generation in diabetic condition   
 i.  General characteristics of diabetic patients  
This study included diabetic patients (n = 80) with a mean age of (60.56 ± 11.63 years) 
and 50 healthy individuals with a mean age of (35.50 ± 10.78 years). The diabetic patie nt 
population was composed of 51 % and 49%, whereas healthy controls 44.37 % and 
55.73 % males and females, respectively (Table 3.2).  
ii. Enhanced endogenous serotonin accelerates free radical generation in diabetic 
patients  
As previously demonstrated that serotonin is involved in the free radical generation 
during certain pathological conditions (Bianchi et al., 2005). In the present study ROS 
level in diabetic patients (Table 3.2) as well as in serotonin treated diabetic animal 
models were measured and results showed significant elevation of the ROS level in 
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diabetic as well as serotonin treated diabetic rats than that of the normal subjects (Table 
3.3, Fig. 3.7). As enhanced serotonin level in the blood of diabetic patients is also 
reported by Hara et al., (2001), these findings suggest a possible link of serotonin to 
free radical production under diabetic condition.  
Table 3.2: Comparison of different parameters between diabetic patients and normal 
subject  
Parameters  Patients (n = 80)  Controls (n = 50)  P- Values  
Age (years)    60.56  11.63  35.50  10.78    <0.0001a  
Male/Female  41/39  31/19    <0.0001a  
Smoker/Non Smokers  52/28  40/8  <0.0001a  
ROS (Absorbance)  0.095  0.0613  0.049  0.032  <0.0001b  
SOD (Units/minutes)    0.039  0.021  0.049  0.026    0.01b  
CAT (units/minute)    1.327  0.145  1.712  0.264    0.01b  
a: P value was calculated by Pearson chi-square test. b: P value was calculated by 
student-t test.  P value considered significant when less than 0.05.  
Table 3.3: General characteristics of an experimental animal model treated with 
alloxan and serotonin  
  Rats body weights (g)  Glucose level (mg/dl)  
 
Groups  
Initial body 
weight  
Final body 
weights  
At 0 day   
At 5th day   
10th 
day   
Alloxan + Serotonin  174  169  92  295  188  
Serotonin  169  192  82  77  74  
Alloxan  202  107  78  415  521  
Saline  173  177  90  99  107  
Animal body weights (at the start of experiment and at the end of experiment) as well 
as the body glucose level before treatment (at the start of experiment) at mid and at 
the end of experiment.  
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iii.  Glucose level and heart weights of serotonin treated diabetic rats  
Elevated blood glucose level is considered a hallmark of both type 1 and type 2 diabetes. 
Glucose levels before, mid (5th day of drug treatment) as well as at the end of treatment 
were measured (Table 3.3). After the administration of alloxan, glucose level increased 
compared to that of the normal rats, but after administration of serotonin glucose 
concentration decreased compared to diseased control group (diabetic group), indicat ing 
the effect of serotonin on glucose level. The heart weight/tibia length ratio was increased 
in serotonin treated diabetic animal model (Fig. 3.9).   
iv.  Serotonin accelerates free radical generation under diabetic condition  
Free radical plays an important role in diabetic complication including cardiac 
hypertrophy. In the present study significantly increased ROS levels were observed in 
the serum of diabetic as well as serotonin treated diabetic rats compared to the normal 
saline treated group (Fig. 3.7). Also a non-significant elevation of ROS levels of 
serotonin treated group than that of normal saline treated group was observed. These 
findings indicate that there may exist a co-relation between serotonin and free radicals 
that further participates in disease progression.  
  
Figure 3.7: ROS analysis in experimental groups (Alloxan+ serotonin, serotonin, 
Alloxan and saline). A): Quantification of serum free radicals. The graphs show the 
average ROS level (absorbance) of different experimental groups. Data are expressed 
as mean ± S.D. Graphs are representative of at least three experiments in triplicates.  
*: P value when less than 0.05  
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v. Down regulation of antioxidant enzymes (CAT and SOD) in serotonin treated 
groups  
The effect of serotonin on antioxidant enzymes after the diabetic condition caused by 
alloxan was assessed. A significant decrease in SOD level was observed in alloxan + 
serotonin compared to the saline group (Fig. 3.8 A). Similarly, down regulation of SOD 
levels in serotonin treated groups was observed when compared to normal saline treated 
group. The catalase levels significantly decreased in alloxan + serotonin and serotonin 
compared to the normal saline treated group, suggesting that serotonin affects the 
antioxidant catalase activity (Fig. 3.8 B, C).  
  
  
Figure 3.8: Down regulation of antioxidant enzymes in serotonin treated diabetic rats. 
A): Antioxidants quantification of serum SOD activities (units/minutes), B and C): 
Serum and heart tissue catalase activities (units/minutes) of experimental groups 
respectively. Graphs are representative of atleast three experiments in triplicates. *: P 
value when less than 0.05.  
vi. Effect of serotonin on histology and cell surface area of experimental model 
heart tissues   
It has previously been reported that serotonin may contribute in cardiac hypertrophy. In 
the present study, effect of serotonin was analyzed after inducing diabetic condition. 
Cell surface area and cellular arrangements were examined. Significant increase in cell 
surface as well as a disorder of cardiac tissues was observed in alloxan + serotonin group 
when compared to other groups, including normal saline treated group (Fig. 3.9 A, C). 
Along with other histological changes, elevations of the ratio between heart weight and 
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tibia length were also calculated (Fig. 3.9 B). These findings suggest a possible link of 
diabetes to cardiac hypertrophy via enhanced serotonin production.   
  
  
Figure 3.9: Enhanced serotonin level in diabetic condition participates in cardiac 
pathologies. Cardiac hypertrophy analysis in experimental groups (Alloxan + 
serotonin, serotonin, Alloxan and saline). A): Cell surface areas (in square micron) 
analysis as a marker of cardiomyocytes hypertrophy B): Experimental group’s heart 
weights/tibia length ratio analysis C): Heart tissue histological assays by hematoxylin-
eosin staining D): Cardiac hypertrophic marker, BNP expression analysis by 
immunoblotting with transferrin as a positive loading control. Graphs, sections and 
blots are representative of at least three experiments in triplicates. *: P value is 
significant when less than 0.05.  
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vii. Expression of Brain Natriuretic peptide (BNP) in heart tissue of experimental 
model  
BNP has a beneficial effect on failing heart which is the hallmark of cardiac disorders. 
Serum BNP expression in treated groups after the diabetic condition was observed by 
standard immunoblotting. Transferrin was used as a positive loading control (Fig. 3.9 
D).  
viii. Serotonin effects on heart valve morphology of diabetic experimental models  
It has been previously documented that increased circulating serotonin induces 
valvulopathy by activation of its different receptors (Droogmans et al., 2007). In the 
current investigation, we assessed the effects of serotonin after diabetic condition. In 
comparison to the normal experimental model we observed altered valvular morphology 
(a sign of cellular fibrosis) in serotonin treated diabetic animal models (Fig. 3.10).  
  
Figure 3.10: Serotonin effects rat heart valves. A, B, and C: serotonin-treated animal. 
The arrows show limited myxoid changes of the leaflets.  Diffuse myxoid thickening of 
the spongy layer reaching the base of the cusps.   
3.1.3. Endothelin-1 induced stress estimation in hypertrophied animal 
model  
 i.  Baseline characteristics of experimental model  
Endothelin-1 (ET-1) has been reported as a stress inducer, involved in stress dependent 
cardio myocytes hypertrophy. Herein, we administrated 2 days of neonatal rat with ET-
1 and ET-1 along with potent antioxidants (NAC and Melatonin). Experimental animals' 
body weights, heart weights and tibia lengths were measured.  
The ratio between heart weights/ tibia length and body weight was used as an index of 
cardiac hypertrophy. Both the ratios were increased in ET-1 treated neonates compared to 
the normal subjects, suggesting the heart hypertrophied condition. In the presence of 
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antioxidant, the ratio between heart and tibia length as well as body weights were slightly 
lower than that of ET-1 treated experimental group (Table 3.4 and Fig. 3.11).  
  
Figure 3.11: Baseline characteristics of experimental animals. A: Heart weights/t ibia 
length, B: heart weights/ body weights. Graphs are representative of at least three 
experiments in triplicates. *: Shows significant difference compared to the normal. P 
values were calculated by multiple comparison test. P value when less than 0.05.  
Table 3.4: Effects of ET-1 on base line characteristics of rats  
Groups   
Initial body 
weights (g)  
Final body 
weights (g)  
Heart weights 
(g)  
Tibia length 
(cm)  
Normal saline  7.73  43.4  0.304  2.3  
ET-1 treated   7.975  32  0.370  2.07  
Melatonin  6.33  37  0.270  2.3  
ET-1+ Melatonin  8.26  31.3  0.35  2.1  
NAC  6.65  42.5  0.29  2.4  
ET-1 + NAC  8.1  28.75  0.24  1.8  
P value   0.02  0.08  0.07  0.008  
Data are presented as group mean. P values (between the groups) calculated by 
ANOVA.   
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ii.  Histological changes in hearts of ET-1 treated rats  
ET-1 is well known for inducing heart histological abnormalities. In the present study 
we also measured the changes occurred in the heart tissues after ET-1 treatment. 
Hypertrophied cardio myocytes with significantly larger cell surface area as well 
nonuniform shape were detected in the ET-1 treated rats hearts compared to the normal 
experimental animal hearts. The cell surface area of cardio myocytes were slightly 
decreased in NAC treated along with ET-1 treated experimental animals, suggest ing 
that NAC is strong antioxidant than that of melatonin and role of oxidative stress in ET-
1 induced hypertrophic condition (Fig. 3.12).   
  
Figure 3.12: Heart histology of experimental model. A: Saline, B: ET-1, C: 
Melatonin, D: ET-1 +Melatonin, E: NAC, F: ET-1 + NAC, G: Cell surface area, 
measured by SPOTCamw. *: shows significant difference compared to the normal 
subjects. P value was calculated through multiple comparison test.  
iii.  GATA 4 and BNP expression in ET-1 induced hypertrophic animal heart 
tissue  
GATA 4 and BNP are considered important stress markers in various reported studies. 
In the present study we measured GATA 4 and BNP expression at proteomic level in 
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the absence and presence of potent antioxidants in ET-1 induced hypertrophic condition. 
Both GATA 4 and BNP expression were higher in ET-1 treated rat heart tissues as 
compared to the normal subjects. In the presence of antioxidants insignificant decrease 
in both the GATA 4 and BNP was detected when blots density was measured (Fig. 
3.13).    
  
Figure 3.13: GATA 4 and BNP expression in heart tissue of experimental rats. A: BNP 
and GATA 4 blots along with actin as a loading control, B: BNP and GATA 4 in ET-1 
treated rats. C and D: BNP blots densitometry analysis in ET-1, ET-1 + NAC/melatonin 
treated rats heart tissues. E and F: GATA 4 blots densitometry in ET1, ET-1 + 
NAC/melatonin treated rats heart tissues.  iv. Free radical status in ET-1 treated rats    
Imbalance of free radical in the presence of inadequate antioxidants is believed to 
generate oxidative stress. To determine oxidative stress condition, free radicals were 
measured and compared statistically. Enhanced levels of free radicals were observed in 
the ET-1 treated rat serum as well as in tissues. To further verify the oxidative stress 
existence in ET-1 induced hypertrophic condition, animals were treated with potent 
antioxidants (NAC, Melatonin) along with ET-1.  In the serum, the free radical status 
was approximately near to the normal values but also lower than ET-1 treated group. 
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While at tissue level insignificant decrease in free radicals was detected when compared 
to ET-1 treated group with antioxidants (NAC and Melatonin) treatment (Fig. 3.14).  
Free radical involvement in lipid peroxidation has been reported previously. Herein, we 
have also estimated the free radical existence through performing TBARS assay. 
Significantly increased TBARS level was detected in the ET-1 treated animal model 
than that of normal subjects, confirming free radical elevation in the presence of ET1. 
TBARS level in the heart tissues of experimental rats treated with antioxidants (NAC 
and Melatonin) was lower than ET-1 treated group (Fig. 3.15). These findings suggest 
that ET-1 induce oxidative stress via free radical generation.    
  
Figure 3.14: Reactive oxygen species (ROS) status in the serum and homogenates of 
experimental models. A: Serum ROS level, B: Heart tissue ROS level. *: shows 
significant difference compare to the normal control (saline). P value consider 
significant when less than 0.05.  
  
Figure 3.15: Heart tissue TBARs level of experimental animal model. *: shows 
significant difference compare to the normal control (saline). P value consider 
significant when less than 0.05.  
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v.  ET-1 impaired antioxidants enzymes activities in experimental rat models   
It has been reported that oxidative stress is generated in the absence or due to inadequate 
antioxidant activities. To confirm and to co relate the ET-1 with oxidative stress, the 
antioxidants activities in the absence and presence of potent antioxidants were 
determined both in serum as well as at tissue level. Significant decrease in serum SOD 
activity was observed in the ET-1 treated rats, however, at tissue level we did not 
detected significant relation of SOD activity between ET-1 treated and normal subjects. 
SOD activity was insignificantly recovered in the rats treated with ET-1 along with 
NAC and melatonin (Fig. 3.16 A, B).   
Catalase also plays a key role in the ROS elimination. Its activity was also measured in 
the serum as well as in the homogenates of heart tissues. Significant decrease in catalase 
activities was detected in the serum and at tissue level in ET-1 treated rats when 
compared to normal subjects. Serum catalase activity in ET-1 + potent antioxidant 
(NAC, melatonin) experimental model was recovered. However, at tissue (heart tissue) 
level, catalase activity was comparatively less than normal saline treated rats (Fig. 3.16 
C, D). These finding postulates the key role of SOD and catalase against oxidative stress 
during hypertrophic condition.   
  
Figure 3.16: Antioxidants status in experimental animal model. A and B: serum and 
tissue SOD activities respectively. C and D: Serum and heart tissue catalase activities 
respectively. *: shows significant difference compared to the normal control (saline).  
P value consider significant when less than 0.05.  
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3.1.4. Isoproterenol (ISO) induced stress estimation in hypertrophied 
animal model  
 i.  Isoproterenol induced alteration in heart weights of animal model  
Isoproterenol (ISO) has been documented as a strong stress dependent cardiac disorder 
inducer. Herein, isoproterenol has been administrated to experimental animals to induce 
cardiac pathologies including cardiac hypertrophy. The baseline characterist ics, 
including body weights, heart weights and tibia lengths were measured. As alteration in 
the ratio of heart weight and tibia lengths/ body weight has been considered as disease 
condition, so in the present study we also determined the respective ratios. Increase in 
both heart weight/tibia lengths and body weights were observed, supporting the cardiac 
pathological condition including cardiac hypertrophy. While using antioxidants as 
oxidative stress regulator, we did not detect any significant difference in disease control 
and antioxidant treated animal models (Table 3.5, Fig. 3.17)  
Table 3.5: Baseline characteristics of animal models  
Groups   Initial body 
weights (g)  
Final Body 
weights (g)  
Heat weights  
(g)  
Tibia lengths 
(cm)  
Saline  112.75  120.75  0.525  3.425  
ISO   118  138.25  0.790  3.225  
Melatonin  108  139.8  0.52  3.46  
ISO + Melatonin  121  162.75  0.795  3.27  
NAC  108.2  131.4  0.51  3.42  
ISO + NAC  109.8  104.2  0.629  3.16  
P value  0.01  0.001  <0.0001  0.047  
Data are presented in group Mean. P values (between the groups) calculated by 
ANOVA.   
ii.  ISO induced histopathological changes  
Histological changes with ISO treatment in the heart of experimental model were 
measured and analyzed. After hematoxylin and eosin staining the cardiac morphology 
and cardio myocytes surface area was assessed.  Cardio myocytes in ISO treated heart 
were hypertrophied, non-uniform in shape, and disorganized in arrangement (p = 
<0.0001) compared to the normal heart. Cell surface areas in ISO + NAC and ISO + 
melatonin treated rats are lower than that of ISO treated experimental rat heart (Fig. 
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3.18). Increase in cell surface area and elevated heart weight and tibia length ratio (Fig. 
3.17) suggest the cardiac hypertrophic condition of rats heart with ISO treatment.   
  
Figure 3.17: Heart weights/tibia length and body weight ratios. A: heart weights/tibia length, 
B: heart weights/body weights. *: shows significant difference compared to the normal 
control (saline). P value consider significant when less than 0.05.  
  
Figure 3.18: Histopathology of ISO treated experimental animal models. A: Saline, B: 
ISO, C: Melatonin, D: ISO +Melatonin, E: NAC, F: ISO + NAC, G: Cell surface 
area, measured by SPOTCamw. *: shows significant difference compared to the 
normal control (saline). P value consider significant when less than 0.05.  
iii.  GATA4 and BNP expression   
GATA4 and BNP high expression has been documented in mal adaptive cardiac 
hypertrophic conditions. In the present study we analyzed the GATA4 and BNP 
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expression in animal heart tissue by immunoblotting. Both the GATA4 and BNP 
expressions were increased in the ISO administrated rats heart compared to the normal 
subjects. After co administration of ISO and melatonin, we did not find any significant 
difference in BNP and GATA 4 expression between ISO treated and ISO + melatonin 
treated. However, in the presence of NAC the GATA 4 and BNP expressions were 
decreased in ISO + NAC compared to the ISO treated rats heart tissue (Fig. 3.19). These 
finding suggests that there might be a link of oxidative stress and ISO induced cardiac 
hypertrophy.   
  
Figure 3.19: GATA4 and BNP expression in the heart tissues of experimental rats. A 
and B: BNP, GATA 4 and actin blot in experimental models respectively. C, D, E and 
F: BNP and GATA 4 blots densitometry graphs.   iv.  ISO induces free 
radicals regulation  
Excessive production of free radical participates in the imbalance of redox homeostasis 
which ultimately leads to the oxidative stress. To confirm the oxidative stress in the ISO 
induced cardiac hypertrophic condition both in serum and in heart tissue free radical 
level were measured. Elevated levels of free radicals both at serum as well as at tissue 
level were observed when compared to the normal control subjects. To confirm further, 
animal models were subject to combined treatment with ISO and antioxidants. 
Significant decrease in the serum free radicals was detected in the case of NAC 
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compared to normal as well as ISO treated rats. But, at tissue level, we observed non-
significant decrease in the free radicals compared to normal control, however, when 
compared to hypertrophied animal model significant down regulation of free radicals 
was observed. In case of melatonin both serum and tissues showed non-significant 
decrease in free radical level (Fig. 3.20).   
Lipids peroxidation is also considered as the result of free radical over productions. 
Herein, TBARS assay was also performed to estimate free radical level. Significant 
levels of TBAR in ISO treated animals were observed compared to other experimenta l 
groups. While after antioxidants (NAC and melatonin) treatment TBARS level was 
decreased compared to the ISO treated group (Fig. 3.21). These findings suggest ISO 
induce free radical generation during the cardiac hypertrophic condition.  
  
Figure 3.20: ROS level in the serum and heart tissue of experimental animal model. A: serum 
ROS level, B: heart tissues. *: Represent ISO treated comparison to the normal.  P value when 
less than 0.05.  
  
Figure 3.21: TBARS level in heart tissue of experimental animal model. *: Represent ISO 
treated comparison to the normal. P value when less than 0.05.  
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Figure 3.22: Serum and heart tissue antioxidants activities in ISO treated experimental model. 
A and B: Serum and heart tissue SOD activities. C and D: Serum and tissue catalase 
activities. *: shows significant difference compare to the normal control (saline). P value 
consider significant when less than 0.05 and was measured by Tukey’s multiple comparison 
test.    
v. Estimation of ISO impaired antioxidant enzyme activities in experimental rats  
Antioxidants, including SOD and catalase activity in serum as well as in heart tissue 
homogenates were measured. SOD activities were reduced both in the serum and tissues 
in ISO treated rats compared to the other groups (Fig. 3.22 A, B). Similarly, reduced 
catalase activity was observed in the ISO treated rats compared to the normal subjects. 
Both SOD and catalase activity were increased or equal to normal saline treated rats 
with melatonin and NAC treated experimental animals. In ISO + melatonin and ISO + 
NAC treated rats, SOD activities were found almost same as normal control groups. 
However catalase activity got increased in the ISO + NAC heart tissues while in ISO + 
melatonin heart tissue it was slightly increased when compared to the ISO treated 
experimental animal models (Fig. 3.22 C D).   
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3.1.5. Stress regulation in TAC and CnA-Tg transgenic model  
 i.  Stress markers expression in experimental model  
Several stress markers are used to assess the presence of stress in the different cardic 
hypertrophic experimental models including TAC and CnA-Tg mice model. In the 
present study ANF and alpha skeletal actin were selected and measured at 
transcriptional level via RT-PCR. Significant increase in  the ANF (in TAC) and 
sarcomeric a-actinin was observed when compared to the normal subjects. However in 
CnA-Tg, non significant increase in ANF relative mRNA expression was observed 
when compared to the vehicle (Fig. 3.23). The reactivation of fetal gene expression in 
experimental model confirmed the stress involment in cardiac hypetrophic condition.   
  
  
Figure 3.23: Stress mRNA expression in vehicle, TAC and calcinurin transgenic mice.  
*: Shows significant difference compared to normal subjects. P value when less than  
0.05 and is calculated through student t. test.   
ii.  Histopathology of experimental mice   
To further confirm the hypertrophic condition of the experimental animal, haematoxylin 
and eosin staining was performed (Fig. 3.24). The cell surface areas were measured and 
compared statistically. Larger heart sizes with hypertrophied cardio myocytes of non-
uniform shape were detected in the TAC and transgenic animal model compared to the 
control subjects, confirming the cardiac hypertrophic condition.   
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Figure 3.24: Histology of the TAC and CnA-Tg experimental rats  
iii.  Source of oxidative stress, The NOX4 expression in the experimental 
model  
NADPH oxidase family member, NOX4 has been documented as enzymatic source of 
oxidative stress. In the present work we measured the transcriptional level expression 
of NOX4 in the sham, TAC and calcineurin transgenic (CnA-Tg) mice heart tissues. 
Enhanced  expression of NOX4 was observed in tansgenic, and TAC compared to the 
control subjects (Fig. 3.25). This investigation suggests that during stress (in the TAC 
and transgenic mice cardiac hypertrophic model)  free radicals were generated that 
further play role by different pathways.   
  
Figure 3.25: NOX4 expression in TAC and calcineurin transgenic model. *: 
Represent significant difference compared to normal subjects. P value consider 
significant when less than 0.05 calculated by student t test.   
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 Figure 3.26: Antioxidants enzymes expression. A: Relative mRNA SOD1, B: relative 
mRNA SOD2, C, D, E: Post translational expression of SOD2 and catalase optimized 
through GAPDH. *: P value when less than 0.05 and was calculated by student t test.  
iv. Antioxidants enzymes expression in TAC and CnA-Tg transgenic model  
To determine the effects and co relation of stress generated in TAC and calcineur in 
transgenic models, we measured the expression of free radical scavengers including the 
SOD1 and SOD2 while using L7 as control standard in cardiac tissues of animal model. 
Unstable expression of SOD1 at transcriptional level was observed in both conditions. 
Post transcriptional level decline of CAT was detected while using high detection 
chemifluorescence reagents. The first line defense against free radical includ ing 
antioxidant SOD2 (mitochondrial) was determined in both experimental models. Both 
at transcriptional as well as at post transcriptional level, SOD2 levels got markedly 
reduced as a result of persistent generated stress in the experimental models (Fig. 3.26). 
Thus the current findings suggests that due to the unstable antioxidants, in body free 
radical generation occurred in the TAC and calcineurin transgenic model which further 
participates in cardiac pathologies.   
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Figure 3.27: SOD2 relative expression in transgenic animal models. *: shows 
significant difference to normal subject. P value when less than 0.05 and was 
calculated by student t test.   
v.  SOD2 expression in MI and miR-199b transgenic mice   
To determine the role of SOD2 as regulatory target of miR-199b, we first checked the 
binding site of miR-199b at SOD2 3’UTR regions (Fig. 3.33) and then mRNA level 
expression in the miR-199b transgenic animal models was assessed. No significant 
difference of SOD2 at mRNA level was observed between the wild type and transgenic 
model cardiac tissue (Fig. 3.27). These finding suggests that SOD2 may not be a direct 
target of miR-199b.  
We further verified the SOD2 expression in transgenic myocardial infraction transgenic 
model. While comparing with wild type we found significant decrease in SOD2 
expression in transgenic model suggesting its role in myocardial infraction (Fig. 3.27).    
3.1.6. Stress estimation in neonate rats cardio myocytes (NRCM) 
treated with endothelin-1 (ET-1) and phenylephrine (PE)  
 i.  PE and ET-1 treated NRCM  
Neonatal rat cardio myocytes have been used since long time for in vitro studies. In the 
present study, to correlate and to induce the stress conditions, NRCM were treated with 
phenylephrine (PE) and endothelin-1 (ET-1). Hypertrophic condition of the cardio 
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myocytes was confirmed by cell surface area measurement. While comparing with 
normal control (serum free) increased cell surface areas in PE and ET-1 treated was 
detected (Fig. 3.28).   
  
  
Figure 3.28: PE and ET-1 treated NRCM and cell surface area measurement. A: 
Serum free, B: PE treated, C: ET-1 treated. *: Represent significant difference 
compared to the normal subjects. P value when less than 0.05 and was measured by 
student t test.   
  
  
Figure 3.29: Stress markers expressional analysis in NRCM after PE treatment  
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ii.  Stress markers measurement in NRCM  
ET-1 and PE can induce stress as previously described (Jain  et al., 2012; Gan et al.,  
2009). Stress markers including BNP, ANP, α-actinin as shown in fig. 3.29 were 
measured at transcriptional level by qPCR after ET-1 and PE treatment. The expression 
of stress markers confirmed the stress induction in cardiomyocytes. Stress alter the cell 
size as well as vasculature and in the present study we observed large cell sizes (Fig. 
3.28) suggesting a step toward cardio myocytes hypertrophy.  
iii.  Effects of stress inducer (PE and ET-1) on NRCM antioxidants enzymes   
Antioxidant enzymes including SOD1, SOD2 and catalase mRNA expressions were 
also determined in the PE and ET-1 treated cardio myocytes. Insignificant decrease in 
the SOD1 mRNA was detected, while the expression of SOD2 (that is a mitochondria l 
antioxidant) mRNA was significantly reduced in both PE and ET-1 treated cardio 
myocytes. Similarly, the catalase, a hydrogen peroxide scavenger mRNA expression 
was also decreased in both PE and ET-1 treated NRCM (Fig. 3.30). These find ings 
suggests that PE and ET-1 treatments generate free radicals which are further involved 
in the redox signaling playing a significant role in the stress dependent cardio myocytes 
hypertrophy.   
  
Figure 3.30: Antioxidants enzymes relative mRNA expression PE and ET-1 treated 
NRCM. A: SOD1, B: SOD2, C: Catalase. *: Represent significant difference 
compared to the normal subjects. P value when less than 0.05 and was measured by 
student t test.   
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3.1.7. HL-1 treatment with H2O2 to induce stress   
 i.  H2O2 treated HL-1 cells and expression of stress markers (BNP and ANF)  
To check the reactive oxygen species co relation with cardiac hypertrophy, stress 
markers which play important role in the hypertrophic condition were measured at 
mRNA level in the hydrogen per oxide treated HL-1 cells. After comparison with the 
untreated control the mild expressions of BNP was observed in both 50 as well as 100 
µM H2O2 treated HL-1 cells. Similarly, high expression of ANF was detected in the 100 
µM H2O2 treated HL-1 cells line. However, in 50 µM H2O2 treated condition the mild 
expression of the ANF suggests the concentration dependent expression but it needs 
further investigations (Fig. 3.31). These findings suggest that reactive oxygen species 
induced stress (oxidative stress) contributes in several diseases including cardiac 
hypertrophy.   
  
Figure 3.31: BNP and ANF relative expression in H2O2 treated HL-1 cells. A: BNP 
relative expression in HL-1 cells. B: ANF relative expression in HL-1 cells. *: 
Represent significant difference compared to the normal subjects. P value when less 
than 0.05 and was measured by student t test.   
ii.  SOD2 expression in HL-1 cells   
SOD are considered the first line of defense against free radicals. We specifica lly 
checked the SOD2 level in the HL-1 cells upon H2O2 treatment. Concentration 
dependent expressions of SOD2 was observed. At 50 µM H2O2 concentration, mild ly 
reduced SOD2 expression was detected while on increasing the concentration of H2O2 
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(100 µM) further decline in SOD2 expression was observed (Fig. 3.32). These results 
suggest that persistent oxidative stress may participate in decreasing the antioxidant 
enzymes level but it needs further experimental studies.   
  
  
Figure 3.32: SOD2 expression in H2O2 treated HL-1 cells. *: Represent significant 
difference compared to the normal subjects. P value when less than 0.05 and was 
measured by student t test.   
3.1.8. Role of microRNA (miRNAs) in cardiac pathologies  
i. miRNAs expression in  TAC and CnA-Tg mice heart tissue  
MicroRNA are known to play a critical role in the post transcriptional gene regulat ion 
through imperfect binding to 3’ untranslated region (UTR) of messenger RNAs. Herein, 
we selected and predicted microRNA which may directly or indirectly involve in the 
SOD2 regulation through their putative binding regions in the 3’UTR region of SOD2 
(Fig. 3.33). Some miRNAs including miR-132, miR-212, miR-155 were down 
regulated in transgenic mice compared to sham group. However, in TAC model 
increasing trend in miR-132 and miR-155 was detected. The miR-142 and miR-92b 
were also down regulated in the both TAC as well as in CnA-Tg mice model heart 
tissues. The other selected miRs including miR-199b, miR-152 and miR-146b were up 
regulated in the both experimental animal model compared to the control subjects (Fig. 
3.34). These findings suggests miRNA regulation in both stress models.   
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Figure 3.34: MicroRNA expression analysis in TAC and transgenic mice heart 
tissues. A: miR-132, B: miR-212, C: miR-155, D: miR-17, E: miR-199b, F: miR-152, 
G:miR-92b, H: miR-142, I: miR-146b. *: Represent significant difference compared to 
the normal subjects. P value when less than 0.05 and was measured by student t test.   
  
Figure 3.33. SOD2 3’UTR sequence presentation   
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ii. miRNAs expression in ET-1 treated animals heart tissues  
Selected miRNAs were studied in heart under ET-1 induced stress condtion, while using 
NAC and melatonin as an antioxidants. The miR-152 which has been reported to be 
involved in the cardiac disroder (Ioannis et al., 2008)  was upregualted in ET-1 treated 
rats heart compared to the normal subjects. Insignificant difference in miR-152 
expressions between ET-1 and ET-1 + NAC as well as ET-1+ melatonin was detected 
(Fig. 3.35 A and D). miR-132 was also up regualted in heart tissue under ET-1 induced 
hypertrophic condition. However, upon anti-oxidants treatement miR-132 was down 
reguated (Fig. 3.35 B and E), showing a link between oxidative stress and miR-132 
family but it needs further investigation. The miR-142-3p is down regualted in cardiac 
hypertrophic condition as reported previously (Salil et al., 2012). To link the oxidative 
stress we also measured miR-142-3p expression in ET-1 + antioxidants (NAC and 
melatonin) treated rats hearts. Significant down regulation of miR-142-3p in ET-1 
treated experimental rats was observed. However, in the present investigation no 
significant difference in miR-142-3p expression was detected (Fig. 3.35 C and F).    
  
Figure 3.35: miRNAs expression under ET-1 induce stress condition. A and D: 
miR152, B and E: miR132,  C and F: miR-142-3p. *: Represent significant difference 
compared to the normal subjects. P value when less than 0.05 and was measured by 
student t test.   
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iii.  miRNAs expression in isoprotrenol (ISO) treated animals heart tissues  
The miRNAs expressions were also measured in ISO treated experimental rat hearts. 
miR-152 was upregualted in ISO treated rats. No significnat difference was detected 
between ISO treated and ISO coantioxidants administrated animal heart tissues (Fig. 
3.36 A and D). Similarily, miR-212 was also upregualted in ISO treated rats compared 
to the normal subjects. However, a decrease in miR-212 was detected in the presence of 
potent antioxidants (Fig. 3.36 B and E). Significant down regulation of miR-142-3p in 
ISO treated rats was detected. While in the case of ISO + NAC as well as ISO + 
melatonin treated miR-142-3p was up regulated compared to the ISO treated group (Fig. 
3.36 C and F). These findings suggests a link of oxidative stress and miRNAs expession 
in cardaic hypertrophy but it needs further investigation.   
  
  
Figure 3.36: miRNAs expresssion under ISO induced stress condition in rat hearts 
tissues. A and D: miR-152, B and E: miR-212,  C and F: miR-142-3p. *: Represent 
significant difference compared to the normal subjects. P value when less than 0.05 
and was measured by student t test.   
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iv.  Oxidiative stress link to microRNAs  
It has been documented that under stress conditions, regulatory functions of miRs 
become more pronounced and seems to play more decisive roles in disease signaling. 
To determine miRNA link to stress (oxidative stress) HL-1 cells were selected and 
treated with different concentration of  hydrogen peroxide (H2O2). At 100 uM 
concentraion of H2O2 except the miR-142 and miR17 all the other selected miRs 
including miR-132, miR-155, miR-92b, miR-152 miR199b and miR-146b were up 
regualted. However, at 50 uM concentration, there was differential regulation of 
miRNAs. The  miR-132, miR-155, miR-92b, miR-199b and miR-212 were up 
regulated. The miR-142, miR-17 were down regulated while the level of miR-152 and 
miR-146b remain unchanged compared to the control (Fig. 3.37). The present find ings 
suggests  stress relation to miRs regulation.  
  
  
Figure 3.37: miRNAs expression in H2O2 treated HL-1 cells. A: miR-132, miR-155, 
miR-92b, miR-152. B: miR-142, miR-212, miR-17, miR-199b, miR-146b. *: Represent 
significant difference compared to the normal subjects. P value when less than 0.05 
and was measured by student t test.   
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Part (2) 3.2: Stress role in hematopathalogies including acute 
leukemia   
3.2.1. Acute leukemia and oxidative stress  
 i.  Clinical and Basic characteristic of Acute Leukemia (ALL and AML)  
The study comprised of 60 acute lymphoblastic and myeloid leukemia 60 (each 30) 
patients and 30 healthy individuals. Different clinical parameters of leukemic (ALL, 
AML) patients, such as haemoglobin and platelets are summarized in tables (3.6 and 
3.7). Platelets concentration was significantly higher in the serum of leukemia patients 
as compared to healthy control individuals (P = <0.0001). Serum hemoglobin level was 
down regulated in acute leukemia patients than that of normal subjects (Table 3.6 and 
3.7).   
Table 3.6: Comparison between different parameters of AML patients and 
normal subjects   
Parameters  Patients (n = 30)  Controls (n = 30)  P value   
ROS (Absorbance)  0.27 ± 0.15     0.17 ± 0.154   0.0007a  
SOD (Absorbance)  0.114 ± 0.073  0.37 ± 0.021    <0.0001a  
Age (Years)    27.33 ± 13.36  24.34 ± 1.28    0.3006a  
Smokers/Nonsmoker  9(30%)/ 21(70%)  5(16.33%)/25(83.66%)  0.3598b  
Male/Female  12(40 %)/18(60%)  17(56.66%)/13(43.33%)    0.3014b  
Platelets (uL)   139567 ± 218222  308420 ± 89516  <0.0001b  
Hemoglobin (g/uL)  8.5071 ± 1.80  15.04 ± 0.906  <0.0001b  
AML: Acute myeloid leukemia a: p values were calculated by Mann-Whitney test.   
b:p values were calculated by Chi-Square test.   
  
ii.  Acute leukemia (lymphoblastic and myeloid) and ROS   
The results of the elevation of ROS level are shown in Table 3.6 and 3.7. The serum of 
both AML as well as ALL patients exhibited higher ROS level than that of healthy 
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controls. The present results proposed a significant co relation of ROS to acute 
leukemia.   
iii.  Acute leukemia (lymphoblastic and myeloid) and SOD Activity  
A strong association exists between oxidants and antioxidants in diseases. In the current 
investigation serum SOD level, acting as an antioxidant was measured. The serum SOD 
activity was significantly decreased in both acute lymphoblastic as well as myelo id 
leukemia serum compared to healthy individuals (Tables 3.6 and 3.7) suggesting its 
imbalance in acute leukemia.  
Table 3.7: Comparison between different parameters of ALL patients and normal 
subjects  
Parameters    Parameters    Controls (n = 30)  P value     
ROS (Absorbance)  0.333 ± 0.165    0.172 ± 0.154   <0.0001a  
SOD (Absorbance)  0.091 ± 0.059    0.37 ± 0.021  <0.0001a  
Age  (Years)  7.45 ± 4.64    24.3 ± 1.28  <0.0001a  
Smoker/Nonsmokers  12(40%)/ 18(60%)  5(16.33%)/25(83.66%)      0.0856b  
Male/Female  23(76.66%)/7(23.33%)  17(56.66%)/13(43.33%)  0.1709b  
Platelets (uL)   136087 ± 142447  308420 ± 89516  <0.0001b  
Hemoglobin (g/dL)  9.141± 2.663    15.07 ± 0.9066  
<0.0001b  
ALL: Acute lymphoblastic leukemia. a: p values were calculated by Mann-Whitney 
test. b: p values were calculated by Chi-Square test.  iv.  Trace Elements in the 
Serum of leukemia  
Trace elements have been selected for this study which are likely to be involved in 
different types of cancer including leukemia. Serum Fe concentrations were 
significantly decreased in AML as well as in ALL when compared to the normal healthy 
controls. Similarly, the Zn serum levels were also decreased in acute leukemia (AML, 
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ALL) conditions than that of the healthy subjects.  Serum Cu levels in both AML and 
ALL were higher than that of the normal individuals. Similarly, the average 
concentration of Ni in acute leukemia was increased compared to the normal subjects 
(Table 3.8).  
Table 3.8: Serum level of Trace Elements (ug/ml) in Acute Myeloid, 
Lymphoblastic Leukemia and Control subjects.  
Elements   Control (n= 30)  AML (n = 30)   ALL (n = 30)    P values    
Fe  87.28 ± 17.23  58.22 ± 15.92  67.45 ± 19.24  <0.0001a, <0.0001b  
Zn  93.33 ± 19.60  68.09 ± 17.88  70.01 ± 18.21  <0.0001a, <0.0001b  
Cu  88.02± 15.46  102.4 ± 21.99  95.44 ± 20.07  0.013a, 0.304b  
Ni  27.49 ± 6.10     29.70 ± 10.31  35.65 ± 14.14  0.705a, 0.011b  
AML: Acute Myeloid Leukemia. ALL: Acute lymphoblastic Leukemia. a: AML vs  
Control, b: AML VS Control. P value was considered significant when less than 0.01  
3.2.2 Stress and hematotoxicity   
Study design  
The role of oxidative stress in hematotoxicity was addressed through ROS measurement 
after fresh blood (acute leukemia patient’s) administration to neonatal rats (Fig. 3.38). 
The experimental rats were also administrated with B. persicum seeds extracts. The 
hematotoxic condition were determined by measuring blood parameters along with free 
radical estimation. As a result anti-hematotoxic role of B. persicum seeds was observed 
via free radical regulation but it needs further specified investigations at molecular level.  
 i.  Hematological parameters and plant extracts  
Hematological parameters in various study groups treated with differentia l extracts of 
B. persicum seeds are presented in table 2.8 (material methods section) and Fig. 3.39. 
Group D (disease control group) showed an increase in monocytes, basophils, and 
eosinophils % values and a decrease in % neutrophils, RBC (g/dL), and platelets count 
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when compared with their corresponding values among normal rats. Among the treated 
(butanol, ethyl acetate fraction) groups, % monocytes and % basophils decreased 
significantly when compared to Group D (normal leukemic blood induced group). 
Similarly, significant increase was observed in RBCs (g/dL) and platelet 
concentration/counts compared with those of disease controls (Fig. 3.39). In the case of 
Group A (leukemic treated with aqueous fraction), platelet levels were observed to be 
elevated compared to the disease control group (Fig. 3.39), whereas % of monocytes 
and RBCs decreased  
  
  
Figure 3.38: Hematotoxicity induction in neonatal rats via acute leukemia patient fresh blood 
administration.   
.  
ii.  Effects of plant extracts on ROS level  
Elevated concentrations of free radicals are considered toxic for biological systems. The 
level of free radicals in the hematotoxic group (Group D) was high compared with that 
of normal rats in Group C (Fig. 3.39 G). After the administration of plant extracts, a 
significant decrease in ROS was observed only in Group E, whereas in Group B the 
decrease was nearly significant (p = 0.059).  
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iii.  Effects of plants extracts on blast cells  
Large numbers of blast cells were observed in the disease control group as compared to 
the normal control group. The number of blast cells seen in EFT and BFT were lower 
when compared with that of the disease control group but higher than that of the normal 
control group (Fig. 3.40).  
  
  
Figure 3.39: Effect of differential fractions extracted from the seeds of Bunium 
persicum on different hematological parameters compared from CBC results and free 
radical concentration in serum. Groups A, B, E, and H were administered 
intraperitoneally (i.p.) with nontoxic dose of 300 mg/kg of rat body weight of each 
fraction in 5% Tween solution for 9 consecutive days. Groups C and D were assigned 
as vehicle controls and were only injected (i.p.) with 0.5 mL/d of 5 % Tween solution. 
Mean values were compared using one-way ANOVA followed by Tukey test. *A p value 
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< 0.05 indicates significant difference from the control disease (group D) values. (A) 
Percentage of basophils in different groups. (B) % of eosinophils. (C) % of neutrophils. 
(D) Numbers of platelets. (E) RBC counts. (F) % of monocytes. (G) Level of ROS in 
different groups. ANOVA Z analysis of variance; CBC Z complete blood count; RBC Z 
red blood cell; ROS Z reactive oxygen species.  
  
Figure 3.40: Bone marrow smear stained with Giemsa stain. The blast cells are 
indicated by an arrow in each figure. (A) Control disease. (B) Normal. (C) Blast cell 
in EFT. (D) Blast cells in BFT.  
  
  
  
  
  
 
 
 
4.1: Stress regulation in cardiac dysfunctions  
In the course of heart failure, the heart undergoes a remodeling process (Hasenfuss and 
Pieske, 2002; Machackova et al., 2006; Yamaguchi et al., 2015) that involves changes in 
cardiac size, shape and function (Sutton and Sharpe, 2000; Gao et al., 2005). There are 
accumulative evidences showing that oxidative stress generated due to excessive ROS level 
contributes in numerous diseases including cardiac complications. Within the heart cardio 
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myocytes, neutrophils and endothelial cells are considered the cellular sources of the ROS 
generation (Tsutsui et al., 2011). Increased ROS production in failing heart are associated 
with mitochondrial damage and dysfunction (Ide et al., 2001) due to the inadequate 
antioxidants enzymes activities (Borchi et al., 2010). Here in, to highlights the stress 
(oxidative stress) role in cardiac disorders, well known stress inducers includ ing 
hyperglycemia, endothelin-1 (ET-1), serotonin, phenylephrine (PE), and isoproterenol 
(ISO) were selected. The role and effects of oxidative stress were analyzed in the presence 
or absence of potent antioxidants.  
In the previous reports hyperglycemia has been demonstrated as a risk of cardiac 
complication and its intensive management had beneficial effects on cardiac complicat ions 
related deaths (Gaede et al., 2008). Hyperglycemia induced oxidative stress has been 
proven to be the source for the development of diabetes and its related complications in 
experimental animal model (Dewanjee et al., 2009). In the current study increased trend of 
free radicals in hyperglycemic rats both in serum and in heart tissues has an agreement with 
previous findings. The free radicals status in hyperglycemic condition was further 
confirmed by melatonin treatment of hyperglycemic animal model. In the presence of 
melatonin, the free radical levels were insignificantly varying between hyperglycemic and 
normal subjects. Contrary to the free radicals, the antioxidants activities were up regulated 
in the melatonin treated hyperglycemic rats, showing the free radicals and antioxidants co 
relation. Elevated serum lipid levels in diabetes have been proven to be the risk factor for 
cardiovascular diseases (Indu et al., 2013). In our findings increased level of cholesterol 
and triglycerides in hyperglycemic condition are in agreement with previous finding, 
however, in melatonin treated hyperglycemic rats decreased trend of both lipids, suggesting 
ROS link to inadequate lipids profile.   
Previously it was reported that both luminal and oral glucose levels induce the release of 
serotonin from enterochromaffin cells of the gut, and these receptors for serotonin present 
on the surface of many types of gut cells are responsible for the activities of serotonin 
(Bianchi et al., 2005; Foussal et al., 2010). Hara et al (2011) reported increased serotonin 
concentrations in patients with DM. Similarly, Bainchi et al (2005) determined the role of 
serotonin in cardiac myocyte hypertrophy via ROS generation. Based on this evidence, we 
hypothesized a serotonin-based link of diabetes to diabetic complications, including cardiac 
hypertrophy. The observed decreased glucose levels in serotonin-treated diabetic rats 
confirm the effect of serotonin (Yamada et al., 1989) in an experimental model of diabetes.  
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We demonstrated in our study that free radical generation in diabetes is accelerated through 
serotonin elevation, which contributes further to the pathological condition in diabetes, 
including an imbalance in the body’s antioxidant system. As serotonin induces free radicals, 
which cause different abnormalities, the elevation in serotonin secretion in diabetes links 
diabetes to diabetic complications such as diabetic cardiac hypertrophy. D'Autreaux et al. 
(2007) reported that free radicals play an important role in human physiological and 
pathophysiological processes. ROS react with proteins, lipids, carbohydrates and nucleic 
acids, inducing irreversible functional alterations or complete destruction of cells (Krause 
et al., 2007). ROS is balanced by the body’s natural defense system consisting of 
antioxidant enzymes such as CAT and SOD (Brieger et al., 2012). The increased cell 
surface area (Murtaza et al.,  2011) and heart weights, along with BNP expression in 
serotonin-treated alloxan- induced diabetic rats further support the suggested serotonin-
based link between diabetes and cardiac hypertrophy which is associated with perturbations 
in cardiac myocyte physiology and morphology (Liu et al.,  2014). Previously, serotonin 
role was discussed in disease involvement, but it is not addressed as a link between diabetes 
and cardiovascular disorders as valvulopathy. Therefore, we treated diabetic models with 
serotonin and observed increase in ROS levels, decrease in antioxidant activities and 
impairment of heart valves with reference to normal subjects. Our present investiga t ion 
complies with previous studies, which have shown that serotonin is involved in the 
generation of ROS and valvulopathy (Breard et al., 2007; Elangbam et al., 2008; Fang et 
al., 2013). Serotonin also increases oxidative stress in human heart valve and pulmonary 
artery via MAO-A regulatory mechanism (Pena-Silva et al., 2009). The multifunctiona l 
molecule, serotonin plays a concentration dependent role in platelet’s aggregation 
(Mercado et al., 2013), which further contributes in the pathogenesis of cardiovascular 
disease (Willoughby et al., 2002). Recently, it has also been reported that serum serotonin 
concentration is associated with myxomatous mitral valve disease in dogs (Ljungvall et al., 
2013).  
ISO and ET-1 are well known cardiac hypertrophy inducer (Chowdhury et al., 2013). In the 
present study, hearts hypertrophic condition were confirmed via cardio myocytes 
histological observation and cell surface area measurement. Increased cell surface of cardio 
myocytes with non-uniform shape and hypertrophied form while increased ratio between 
heart weight and tibia length/body weights were observed. The hypertrophic stress 
condition were determined by post translational expressional analysis of stress marker BNP 
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as well as stress regulated transcriptional factor GATA 4. As described previously (Hu et 
al., 2014) increased expression of both BNP and GATA 4 in experimental animal models 
strongly suggests the cardiac hypertrophic condition. To highlight the correlation of ISO 
and ET-1 induced cardiac hypertrophy with oxidative stress the experimental models were 
treated with potent antioxidants (NAC and melatonin) along with ISO and ET-1. Our study 
showed that free radicals significantly increased in ISO and ET-1 treated rats compared to 
the normal subjects both at serum and in heart tissue suggesting free radical involvement 
in ET-1 and ISO induced cardiac hypertrophy. The decline in the body defense system 
including antioxidants enzymes activities has been reported in the previous findings 
(Upaganlawer et al., 2009; Sunmonu and Afolayan, 2010). In the present investigation both 
serum and tissues showed decrease in antioxidant activities in ISO and ET-1 induced 
cardiac hypertrophic condition concurs the previous documented findings. In the presence 
of the potent antioxidants the free radical levels were decreased compared to the 
hypertrophic animal model while antioxidants activities were increased in potent 
antioxidants treated group along with ET-1 and ISO. However, in the same groups, ratio 
between heart weight and tibia length and cell surface area did not decreased, showing that 
use of these antioxidant may be only to reduce the progression of disease but not to recover 
the hypertrophic condition to normal.   
TAC and CnA-Tg mice model has been used as a cardiac hypertrophic model for a long 
time (Muthuramu et al., 2015; da et al., 2010). In the current study, to evaluate the oxidative 
stress status and role in cardiac hypertrophy, these models were used for analysis. The 
hypertrophic conditions were confirmed by heart histology and hypertrophied, non-
uniform, large sized cardio myocytes. The stress status at molecular level was assessed 
through mRNA expression analysis of stress markers including ANF and α-actanin, which 
were up regulated in both model compared to the vehicle. To co relate with oxidative stress, 
NOX4 mRNA analysis was performed. As NOX4 has been reported a strong source of free 
radical (Frazziano et al., 2014; Borchi et al., 2009), in our study increased expression of 
the NOX4 in cardiac hypertrophic condition complies the previous documented reports. To 
address the link and effects of oxidative stress on anti-hypertrophic pathway, element 
comprising antioxidants such as SOD and catalase were analyzed. Non-uniform regulat ion 
of SOD1 was detected mice models heart tissue. The SOD2, which is included in first line 
defense of body against oxidative stress, its expression was significantly down regulated 
both at mRNA as well as at protein level. We did not detect mRNA level of catalase 
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expression, however using high detection chemifluorescence at post transcription level, 
catalase was detected. Catalase expression was significantly decreased in both TAC and 
CnA-Tg mice heart tissue compared to the vehicle subjects. With these findings, it is 
apparent that free radical generation occurred in both TAC and CnA-Tg model and its 
excessive production ultimately leads to the oxidative stress. The persistent oxidative stress 
effects and regulates the cardiac antihypertrophic pathways element including the 
antioxidants enzymes expression but it needs further investigation.   
The normal rat cardio myocytes (NRCM) has been used for in vitro analysis (da et al., 
2010). In the present study NRCM were treated with phenylephrine (PE) and ET-1 for 
inducing cardiac hypertrophy. Non-uniform shape and larger sized cardio myocytes with 
increased cell surface areas confirmed the hypertrophic condition. The stress status were 
estimated through stress markers including BNP, ANF, α-actinin, and βmyosin expression 
in rat cardio myocytes, as these markers up regulated in cardiac hypertrophic condition (da 
et al.,  2010). The down regulation of antioxidant enzymes including SOD1, SOD2 and 
catalase strongly suggests the role of oxidative stress in PE and ET-1 induced cardio 
myocytes hypertrophy.   
Free radicals such as hydrogen peroxide (H2O2) treatment to different cell lines has been 
established in the previous studies (White et al., 2004). In our study, the HL-1, which is the 
cardiac cell line, was treated with different concentrations (0µM, 50µM and 100µM) of 
H2O2. The cardiac hypertrophic conditions were confirmed via up regulation of BNP and 
ANF, which up regulates in cardiac hypertrophic condition (Iemitsu et al., 2005). The 
effects of oxidative stress on the SOD2 expression were estimated by qPCR. Dose 
dependent SOD2 down regulation shows the free radical link to antioxidant enzymes which 
work as anti-hypertrophic agent in case of oxidative stress stimulus for hypertrophy.   
MicroRNAs are well known regulator of gene at post transcriptional level (Cannell et al., 
2008). Previously, reports showed numerous miRNAs participates in the cardiac 
hypertrophy. Recent studies also provide clear evidence that miRNAs modulate a diverse 
spectrum of cardiac functions with developmental, (patho) physiological, and clinica l 
implications (Greco and Condorelli, 2015; Philippen et al., 2015). Understanding the 
miRNAs regulation and identification of tissue specific miRNAs targets 
transgenic/knockout modeling has been a part of investigation in this era (da et al., 2010). 
In the present studies miRNAs which are predicted to be involved in cardiac hypertrophy 
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are selected for analysis. Up regulation of miR-132, miR-212, miR-152, miR-146b, miR-
17, miR-199b and miR-155 in TAC cardiac hypertrophic model has an agreement with the 
previous findings. In case of CnA-Tg miR-152, miR-199b, miR-146b, and miR-17 were up 
regulated. However, miR-142-3p and miR-92b were significantly down regulated in both 
TAC and CnA-Tg mice heart tissue. Previously, it has been reported that like miR-142-3p, 
mir-92b has also been down regulated in cardiac hypertrophy.   
The oxidative stress responsive expression of miRNAs were measured in HL-1 cells treated 
with different concentration of H2O2. Dose depended high expression of miR132, miR-212, 
miR-155, miR-152, miR-199b, and miR-146b were observed, while miR-142-3p and miR-
17 were up regulated. It is apparent that, oxidative stress also participates in the miRNAs 
regulation. As the response of free radical, miRNA expression profile get disturbed 
(Yildirim et al., 2013). Moreover, miRNA expression were analyzed in the presence of 
potent antioxidants in ET-1 and ISO induced hypertrophic condition. miR 152 was up 
regulated in ISO and ET-1 induced cardiac hypertrophy compared to normal subjects. In 
the case of ET-1 + NAC and ET-1 + melatonin, miR-152 expression is decreased than that 
of the ET-1 treated group. However, in ET-1 + NAC group, decrease in the expression of 
miR-152 was not detected when compared to the ET-1 treated group. miR-132 is a strong 
candidate in cardiac hypertrophy (Eskildsen et al.,  2014; Ucar et al.,  2012), its high 
expression has been described previously. In the present study significantly increased 
expression was detected in ET-1 as well as ISO induced cardiac hypertrophic condition 
compared to the normal subjects, complies the previous reports. In the presence of 
antioxidant (NAC, Melatonin) along with ET-1 or ISO, down regulation of miR-132 was 
observed, proposing oxidative stress link to miR-132. Down regulation of miR-1423p has 
been reported previously (Sharma et al., 2012). But the present study showed link of down 
regulation of miR-142-3p in ET-1 as well as ISO induced cardiac hypertrophic stress 
condition. In the presence of the NAC and melatonin reexpression of miR-142-3p strongly 
suggests miR-142-3p co relation to oxidative stress but it needs further investigation.   
In conclusion, unregulated stress in the form of oxidative stress participates in disease 
induction and progression, including cardiac complications. Hyperglycemia, ET-1, ISO, PE 
induce free radical generation which may get reduced through antioxidants. The free 
radicals produced in TAC as well as CnA-Tg mice model may also be considered for the 
hypertrophy progression and transition to heart failure. During cardiac hypertrophy 
induction persistent oxidative stress directly or via miRNAs regulates the anti-hypertrophy 
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elements including antioxidants enzymes expression. The down regulation of these anti-
hypertrophic (antioxidants) elements along with up regulation of miRNAs make it easier 
for oxidative stress to play its role in diseases progression. For the heart patient’s health, 
free radicals generated oxidative stress regulation related strategies in the field of 
therapeutics will be more valuable in future studies.   
4.2: Oxidative stress in hematophatalogies (acute leukemia and hematotoxicity)   
Leukemic cells are going through repeated states of oxidative blockage, which generate 
higher amounts of reactive oxygen species (ROS) than in non-leukemic cells (Kang et al., 
2000). The imbalance of ROS production and the deficiency or significant decrease of 
antioxidants leads to oxidative stress. Severe oxidative stress plays an important role not 
only in DNA damage and mutation of tumor suppressor genes (Kang et al., 2000) but also 
contributes to the promotion of carcinogenesis (Ahmed et al., 1999). In the present study a 
significant elevation in the serum level of ROS suggests its important role in the acute 
leukemia.  
Antioxidant molecules found in cells play a protective role against the excess of ROS. These 
antioxidants (enzymes) including SOD, CAT and GSH work together and require metals 
such as Zn, Cu, Mn and Se as cofactors to eliminate ROS, for their activity (Mates et al., 
1999).  Down regulation of serum SOD in leukemic patients was previously reported (Oltra 
et al., 2001; Senturker et al., 1997). Accordingly, in the Pakistani population the level of 
SOD in acute leukemia patients was also significantly lower than those of the healthy 
individuals. Therefore we hypothesized that decreased SOD concentration and their 
respective effector trace elements are related to leukemia in the Pakistani population.  
Trace elements might influence carcinogenic processes (Geraki et al., 2001). Several metals 
such as iron, copper, cadmium, chromium, lead, mercury, nickel, and vanadium have been 
rated as certain or potential carcinogens by the international agency for research on cancer 
(Navas-Acien et al., 2002; Waalkes, 2003).  They are involved in the generation of ROS 
via the Fenton-like production of superoxide anion and hydroxyl radical, thus leading to 
molecular damage and perturbations in cell homeostasis (Stohs and Bagchi, 1995). Ca, Mn, 
Zn and Cu are essential components of several endogenous antioxidant enzymes (Daniel et 
al., 2004) which defend the body against free radicals.  
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We found that the concentrations of serum Ni and Cu were higher in leukemia patients 
suggesting a link of free radicals and trace elements to acute leukemia. Previously elevation 
of serum Cu, Se (Zuo et al., 2006) as well as Ni and decreased Zn levels were reported in 
leukemia patients (Yang et al., 2008). Similarly, Wen et al. (1989) reported that the levels 
of Cu and Ni were higher in the serum of acute leukemia patients while the concentrations 
of Zn and Mn were lower than that of control subjects. Present findings of increased Cu 
and Ni while decreased Zn and Fe in Pakistani populations suggests a possible link of trace 
elements to acute leukemia in agricultural countries like Pakistan. However, further studies 
are required to identify the actual role of trace elements in leukemia, and to relate enriched 
soil trace elements with their high intake through water and agricultural products.  
Regulation of ROS level is essential for maintenance of normal populations of 
hematopoietic stem cells and their differentiation in normal hemopoetic cell lines (Hole et 
al., 2011; Tothova et al., 2007). ROS in cancer can be targeted by the use of antioxidant 
molecules to suppress the high levels of ROS (Mochizuki et al., 2006). B. persicum is a 
rich source of essential oils including terpenoids, phenolic compounds, and alkaloids, and 
is known to have antioxidant and antimicrobial properties (Sharififar et al., 2010; 
Shahsavari et al., 2008). Different types of synthetic antioxidants such as 
butylatedhydroxytoluene, butylatedhydroxyanisole, propyl gallate, and 
tertbutylhydroquinone are used as additives in food industries. However, researchers have 
shown that these antioxidants are potential carcinogens and can cause internal and external 
bleeding and even death owing to their effects on blood coagulation factor. Because of these 
health-threatening effects of synthetic antioxidants, it becomes crucial to explore natural 
antioxidant compounds as safer substitutes. The seeds of B. persicum are rich in essential 
oils, which have a potent antioxidant activity (Juntachote and Berghofer, 2005). Based on 
the antioxidant activity of B. psersicum, we hypothesize that plant extracts may have 
antihematotoxic effects via an oxygen species dependent mechanism.  
In the present investigation, our finding of increased ROS level compared to the normal 
group is in agreement with previous reports. The treatment using plant extracts such as EFT 
and BFT reduced the ROS level, suggesting that B. persicum plant extracts have a strong 
potential as antioxidants against free radicals. Surprisingly, we found decreased blast cell 
populations in EFT and BFT-treated animals compared to the disease control animals. This 
showed a correlation of free radicals and blast cells; however, this concept may requir e 
further study.  
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Blood is an important index of physiological and pathological status in man and animals, 
and the parameters usually measured are differential leukocyte (white blood cell) count, 
RBC count, and platelet count (Olson et al., 2000; Saha et al., 2012). In the present study, 
an imbalance in the blood picture was observed under diseased conditions. After the 
treatment, the action performed by B. persicum extracts in the regulation of monocytes, 
eosinophils, neutrophils, basophils, and RBCs under toxic conditions showed their potential 
against toxicity.  
In conclusion, our data suggests that imbalance of serum trace elements including Fe, Zn, 
Cu and Ni contributes to pro as well as anti-oxidative stress in acute leukemia. Oxidative 
stress in acute leukemia causes deficiencies in antioxidants enzymes such as SOD and 
proposes a possible link between ROS generated oxidative stress and antioxidants enzymes. 
Finally, the current study aids in designing and improving therapeutic interventions for 
leukemia in regard to ROS regulating enzymes and their cofactors.  
We have also shown for the first time that B. persicum plant differential extracts possess 
antitoxic and anti-oxidative properties against leukemic blood induced hematotoxicity and 
free radicals, respectively. These findings suggest and emphasize that ethyl acetate and 
butanol fractions from the seed extract of B. persicum could be further characterized as a 
valuable therapeutic candidate for the treatment of patients with AML.  
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